Document:

AMD-FASL Patent Cross-License Agreement

 Exhibit 10.55 
  
 AMD-FASL PATENT CROSS-LICENSE AGREEMENT 
  
 THIS AMD-FASL PATENT CROSS-LICENSE AGREEMENT (this “Agreement”) is made and entered into as of June
30, 2003 (the “Effective Date”), by and between Advanced Micro Devices, Inc., a Delaware corporation (“Parent”) and FASL LLC, a Delaware limited liability company (“FASL”). Parent and FASL are
hereinafter also referred to, collectively, as the “Parties” and individually as a “Party.” 
  
 RECITALS 
  
 WHEREAS, FASL was formed for the purpose of conducting the Business; 
  
 WHEREAS, Parent, Fujitsu Limited, a Japanese corporation (“Fujitsu”), AMD Investments, Inc. and
Fujitsu Microelectronics Holding, Inc. have entered into that certain Amended and Restated Limited Liability Company Operating Agreement of FASL LLC as of June 30, 2003 (the “Operating Agreement”); and 
  
 WHEREAS, Parent and FASL each own or control, and may in the future
obtain ownership or control of, various patent rights to which the other Party wishes to acquire a license. 
  
 NOW, THEREFORE, in consideration of the mutual representations, warranties, covenants and other terms and conditions contained herein,
Parent and FASL agree as follows: 
  
 AGREEMENT 

 
 1. DEFINITIONS; INTERPRETATION 
  
 1.1 Capitalized but Undefined Terms. Capitalized terms used in this
Agreement but not defined herein shall have the meaning ascribed to such terms in the Operating Agreement. 
  
 1.2 Terms Defined in this Agreement. The following terms when used in this Agreement shall have the following definitions: 
  
 1.2.1 “Acquired Party” means a Party or the Semiconductor
Group of a Party that has undergone a Change of Control. 
  
 1.2.2
“Acquired Party Covered Product” has the meaning set forth in Section 9.3.3(a). 
  
 1.2.3 “Acquirer” means a Third Party that, through a Change of Control of an Acquired Party, either (a) acquires, through any transaction
or series of related transactions, ownership of securities representing more than fifty percent (50%) of the power to elect Acquired Party’s board of directors or other managing authority, or in the case Acquired Party is a non-corporate
Person, equivalent interests, (b) consolidates with or merges with or into Acquired Party, or has Acquired Party merged into it, or (c) purchases or otherwise receives transfer of all or a substantially all of the assets or business of Acquired
Party. 
  

 1 
  

 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as ****. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 

 1.2.4 “Acquirer Competitive Product” has the meaning set forth in Section 9.3.3(b).

  
 1.2.5 “Acquirer Licensed Patents,” with
respect to an Acquirer to which this Agreement is assigned pursuant to Section 10.6, means all Patents that, as of the effective date of such assignment or thereafter during the Term, are wholly owned by Acquirer, or as to which, and only to the
extent and subject to the conditions under which, Acquirer has the right, as of the effective date of such assignment or thereafter during the Term, to grant licenses or sublicenses without such grant resulting in the payment of royalties or other
consideration to third parties (unless the non-assigning Party undertakes to pay directly or to reimburse Acquirer for any such royalties or other consideration, in which case such Patents shall be included within the Acquirer Licensed Patents),
except for payments to a Subsidiary of Acquirer sublicensed hereunder or payments to Persons for inventions made by such Persons while employees or contractors of Acquirer or any Subsidiary of Acquirer sublicensed hereunder. 
  
 1.2.6 “Assigned Patent Rights” has the meaning set forth in
the Intellectual Property Contribution and Ancillary Matters Agreement. 
  
 1.2.7 “Auxiliary Part” means input/output means, supporting means, terminal members, conductors or equivalent interconnecting members, housing means, any environmental controlling means included within such housing means or
unitary with such housing means and active and/or passive elements unitarily or separately combined with a Semiconductor Product and any other parts, primarily useable in or for manufacturing, assembling or packaging Semiconductor Products.

  
 1.2.8 “Basic Royalty Payment” has the meaning
set forth in Section 6.1. 
  
 1.2.9 “Change of
Control” shall be deemed to have occurred, with respect to a Person (which, for purposes of this Section 1.2.9 also includes the Semiconductor Group of either Party), when: (a) any “person” or “group” (as such terms are
used in Sections 13(d) of the Exchange Act) is or becomes the “beneficial owner” (as defined in Rules 13d-3 and 13d-5 under the Exchange Act) of shares representing more than fifty percent (50%) of the combined voting power of the
then-outstanding securities entitled to vote generally in elections of directors of such Person, or in the case such Person is a non-corporate Person, equivalent interests; (b) such Person consolidates with or merges with or into any other Person,
or any other Person merges into such Person, unless immediately after such consolidation or merger, the Persons that, prior to such consolidation or merger, owned the then-outstanding securities of such Person entitled to vote generally in elections
of directors, or in the case such Person is a non-corporate Person, equivalent interests, own in the aggregate at least fifty percent (50%) of such securities or equivalent interests of the surviving entity; or (c) such Person sells or otherwise
transfers all or substantially all of the assets or business of such Person. 
  
 1.2.10 “Change of Control Date” means, with respect to the Change of Control of a Person, the effective date of such Change of Control. 
  
 1.2.11 “Circuit Patents” means those Licensed Patents that claim a plurality of active and/or passive
elements for generating, receiving, transmitting, storing, 
  

 2 
  

 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as ****. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 

 
transforming or acting in response to electrical signal(s) to achieve a particular function, provided that Circuit Patents shall not include Process
Patents. 
  
 1.2.12 “Coatue Licensed Patents”
means the patent and patent applications set forth on Schedule 1.2.12 and all Patents issuing on such patent applications. 
  
 1.2.13 “Coatue Product” means any Licensed Product that incorporates Polymer Technology and that is manufactured by FASL or for FASL by a
Third Party that is not licensed under the Coatue Licensed Patents. 
  
 1.2.14 “Coatue Royalty Payment” has the meaning set forth in Section 6.2. 
  
 1.2.15 “Control” (including “Controlled,” “Controlling” and other forms thereof), with respect to a
Person, means beneficial ownership, directly or indirectly, of securities representing more than fifty percent (50%) of the power to elect such Person’s board of directors or other managing authority, or in the case of a non-corporate Person,
equivalent interests. 
  
 1.2.16 “Exchange Rate”
means, with respect to any payment by FASL to Parent, the exchange rate for bank cable transfers from the applicable currency to United States dollars as quoted by Citibank, N.A. 
  
 1.2.17 “Effective Date” has the meaning set forth in the first paragraph of this Agreement. 
  
 1.2.18 “Existing Product” of a Person, as of a certain date,
means a Licensed Product developed by or for such Person and being made (or have made) and offered for sale by such Person on or prior to such date. 
  
 1.2.19 “FASL” has the meaning set forth in the first paragraph of this Agreement. 
  
 1.2.20 “FASL Content” has the meaning set forth in the AMD
Distribution Agreement. 
  
 1.2.21 “FASL Licensed
Patents” means all Patents that, as of the Effective Date or thereafter during the Term, are wholly owned by FASL or any of its Subsidiaries that are subject to control by the FASL Semiconductor Group, or as to which, and only to the extent
and subject to the conditions under which, FASL or any of its Subsidiaries that are subject to control by the FASL Semiconductor Group has the right, as of the Effective Date or thereafter during the Term, to grant licenses or sublicenses without
such grant resulting in the payment of royalties or other consideration to third parties (unless Parent undertakes to pay directly or to reimburse FASL and/or its Subsidiaries, as applicable, for any such royalties or other consideration, in which
case such Patents shall be included within the FASL Licensed Patents), except for payments to FASL or any of its Subsidiaries that are subject to control by the FASL Semiconductor Group or payments to Persons for inventions made by such Persons
while employees or contractors of FASL or any of its Subsidiaries that are subject to control by the FASL Semiconductor Group. Notwithstanding any of the foregoing, FASL Licensed Patents do not include any Assigned Patent Rights. 
  

 3 
  

 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as ****. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 

 1.2.22 “Fujitsu” has the meaning set forth in the Recitals. 
  
 1.2.23 “Intellectual Property Contribution and Ancillary Matters
Agreement” means that certain Intellectual Property Contribution and Ancillary Matters Agreement entered into as of June 30, 2003 by and among Parent, FASL, AMD Investments, Inc. and Fujitsu. 
  
 1.2.24 “Licensed Patents” means, collectively, the FASL
Licensed Patents, the Parent Licensed Patents, and the Subsidiary Licensed Patents of each Subsidiary of Parent that, pursuant to Section 5.1, is granted sublicenses of the rights, licenses and immunities granted to Parent under Sections 2, 3 and 4.

  
 1.2.25 “Licensed Product” means any of the
items described in the following clauses (a) through (d) and/or parts thereof: 
  
 (a) Semiconductive Material; 
  
 (b) Auxiliary Part; 
  
 (c) Semiconductor Product; or

  
 (d) Manufacturing Apparatus. 
  
 1.2.26 “Manufacturing Apparatus” means any instrumentality
or aggregate of instrumentalities primarily designated for use in the making of any of the items set forth in clauses (a) through (c) of Section 1.2.25 and/or parts thereof. 
  
 1.2.27 “Net Sales” with respect to a product, means the gross amounts invoiced by FASL and its Subsidiaries
for the sale or other distribution of the product within any country, less (a) separately stated charges for sales and use taxes, excise taxes, customs duties and other similar taxes, and (b) any amounts that FASL and its Subsidiaries
actually paid for the non-FASL Content, if any, of such product. 
  
 1.2.28 “Non-Semiconductor Group,” with respect to a Party, means any of such Party’s internal groups or other organizations that is not the Semiconductor Group of such Party. 
  
 1.2.29 “Operating Agreement” has the meaning set forth in
the Recitals. 
  
 1.2.30 “Parent” has the meaning
set forth in the first paragraph of this Agreement. 
  
 1.2.31
“Parent Licensed Patents” means all Patents that, as of the Effective Date or thereafter during the Term, are wholly owned by Parent, or as to which, and only to the extent and subject to the conditions under which, Parent has the
right, as of the Effective Date or thereafter during the Term, to grant licenses or sublicenses without such grant resulting in the payment of royalties or other consideration to third parties (unless FASL undertakes to pay directly or to reimburse
Parent for any such royalties or other consideration, in which case such Patents shall be included within the Parent Licensed Patents), except for payments to a Subsidiary of Parent sublicensed hereunder or payments to 
  

 4 
  

 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as ****. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 

 
Persons for inventions made by such Persons while employees or contractors of Parent or any Subsidiary of Parent sublicensed hereunder. Parent Licensed
Patents includes Coatue Licensed Patents. 
  
 1.2.32
“Party” and “Parties” have the respective meanings set forth in the first paragraph of this Agreement. 
  
 1.2.33 “Patents” means all classes or types of patents (including design patents) and utility models of all countries of the world issued
or issuing on patent or utility model applications entitled to an effective filing date that is on or before the end of the Term, and respective applications therefor, together with any divisions, continuations and continuations-in-part and reissues
and results of re-examinations thereof. 
  
 1.2.34
“Pending Product” of a Person, as of a certain date, means a Licensed Product developed by or for such Person that such Person reasonably expects to tapeout within eighteen (18) months of such date (as specified in a then-current
written product roadmap as of such date) and that such Person reasonably expects to make (or have made) and sell commencing reasonably promptly thereafter. 
  
 1.2.35 “Polymer Technology” shall have a meaning to be agreed upon by the Parties and Fujitsu. The Parties and Fujitsu will negotiate
such meaning in good faith promptly after the Effective Date. 
  
 1.2.36 “Process Patents” means those Licensed Patents that claim (a) a process for designing and/or making Licensed Products, including equipment used therefor, (b) materials comprising or used in the manufacturing of
Licensed Products, or (c) a structure for the arrangement or interrelationship of regions, layers, electrodes or contacts of Licensed Products. 
  
 1.2.37 “Royalty Payment” means any Basic Royalty Payment or Coatue Royalty Payment. 
  
 1.2.38 “Semiconductive Element” means an element consisting
primarily of a body of Semiconductive Material having a plurality of electrodes associated therewith, whether or not said body consists of a single Semiconductive Material or of a multiplicity of such materials, whether or not said body has, therein
and/or thereon, one or more junctions and whether or not said body includes one or more layers or other regions (constituting substantially less than the whole of said body) of a material or materials which are of a type other than Semiconductive
Material, and if provided as a part thereof, said element includes passivating means thereof. 
  
 1.2.39 “Semiconductive Material” means any material whose conductivity is intermediate to that of metals and insulators at room temperature and whose conductivity increases with increasing temperature
over some temperature range. 
  
 1.2.40 “Semiconductor
Group,” with respect to a Party, means the internal group or other organization of such Party having as its primary activities the research and development and making of Semiconductor Products for, and selling of Semiconductor Products to,
the semiconductor merchant market. The FASL Semiconductor Group currently 
  

 5 
  

 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as ****. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 

 
consists of FASL in its entirety. The Parent Semiconductor Group currently consists of Parent in its entirety. 
  
 1.2.41 “Semiconductor Product” means: 
  
 (a) a Semiconductive Element; or 
  
 (b) a Semiconductive Element and one or more films of
conductive, semiconductive or insulating materials formed on a surface or surfaces of such Semiconductive Element, said film or films comprising one or more conductors, active or passive electrical circuit elements or any combination thereof; or

  
 (c) a unitary assembly consisting of one or
more of the elements described in clauses (a) and/or (b) of this Section 1.2.41 having a fixed permanent physical relationship established therebetween; or 
  
 (d) a unitary assembly consisting primarily of (i) one or more of the elements described in clauses (a), (b) and/or (c) of this Section
1.2.41, and (ii) one or more film devices having a fixed permanent physical relationship established therebetween. 
  
 Semiconductor Product includes, if provided therewith as a part thereof, (A) Auxiliary Parts and (B) additional electrical circuits constituted thereby and integrally
included therein, provided that such Auxiliary Parts and additional electrical circuits are incidental to the functionality of such Semiconductor Products.  
  
 1.2.42 “Semi-Annual Period” means each half of FASL’s fiscal year (i.e., January 1 through June
30, and July 1 through December 31); provided, however, that the first Semi-Annual period shall commence on the Effective Date and shall end on December 31, 2003, and the last Semi-Annual Period shall end on the effective date of any
termination of this Agreement. 
  
 1.2.43
“Subsidiary” of a Party means any other Person that is Controlled by such Party, but such other Person shall be deemed to be a Subsidiary only so long as such Control exists. Notwithstanding the foregoing, neither FASL nor any
Subsidiaries of FASL shall be deemed a Subsidiary of Parent. 
  
 1.2.44 “Subsidiary Licensed Patents,” with respect to a Subsidiary of Parent that, pursuant to Section 5.1, is granted sublicenses of the rights, licenses and immunities granted to Parent under Sections 2, 3 and 4, means
all Patents that, as of the date of sublicense or thereafter during the Term, are wholly owned by such Subsidiary, or as to which, and only to the extent and subject to the conditions under which, such Subsidiary has the right, as of the date of
sublicense or thereafter during the Term, to grant licenses or sublicenses, without such grant resulting in the payment of royalties or other consideration to third parties (unless FASL undertakes to pay directly or to reimburse such Subsidiary for
any such royalties or other consideration, in which case such Patents shall be included within the Subsidiary Licensed Patents), except for payments to Parent or any other Subsidiary of Parent sublicensed hereunder or payments to Persons for
inventions made by such Persons while employees or contractors of such Subsidiary or any other Subsidiary of Parent sublicensed hereunder. 
  

 6 
  

 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as ****. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 

 1.2.45 “Successor Product” means a subsequent or follow-on version of an Acquired Party
Covered Product or Acquirer Competitive Product that is based on substantially the same technology (including “process shrinks” of such products and other incremental improvements thereto) as such Acquired Party Covered Product or Acquirer
Competitive Product without the benefit of fundamental advances in design, and that is intended to replace such Acquired Party Covered Product or Acquirer Competitive Product and to be used in the same type of application (e.g., personal computer,
mobile phone, etc.). 
  
 1.2.46 “Term” means the
period commencing on the Effective Date and ending on the effective date of the termination of this Agreement pursuant to Section 9. 
  
 1.2.47 “Termination Agreement” means that certain Termination Agreement entered into as of June 30, 2003 by and among Parent, Fujitsu,
and FASL (Japan). 
  
 1.2.48 “Third Party” means
any Person other than the Parties and other than any Person Controlling, Controlled by or under common Control with either Party. 
  
 1.2.49 “Transaction Documents” has the meaning set forth in the Contribution Agreement. 
  
 1.3 Interpretation. 
  
 1.3.1 Certain Terms. The words “hereof,”
“herein,” “hereunder” and similar words refer to this Agreement as a whole and not to any particular provision of this Agreement. The term “including” is not limited and means “including without limitation.”
The words “make” and “have made” include the acts of developing, assembling, packaging and/or testing. 
  
 1.3.2 Section References; Titles and Subtitles. Unless otherwise noted, all references to Sections and Schedules herein are to Sections and
Schedules of this Agreement. The titles, captions and headings of this Agreement are inserted for convenience of reference only and are not intended to be a part of or to affect the meaning or interpretation of this Agreement. 
  
 1.3.3 Reference to Persons, Agreements, Statutes. Unless otherwise
expressly provided herein, (a) references to a Person include its successors and permitted assigns, (b) references to agreements (including this Agreement) and other contractual instruments shall be deemed to include all subsequent amendments,
restatements and other modifications thereto or supplements thereof and (c) references to any statute or regulation are to be construed as including all statutory and regulatory provisions consolidating, amending, replacing, supplementing or
interpreting such statute or regulation. 
  
 2. MUTUAL
RELEASE 
  
 2.1 Release by FASL. FASL
hereby releases, acquits and forever discharges Parent hereunder from any and all claims or liability for infringement or alleged infringement of any FASL Licensed Patent by performance of acts prior to the date on which such Patent becomes a FASL
Licensed Patent that, if performed on or after such date, would be acts licensed, sublicensed or immunized hereunder. 
  

 7 
  

 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as ****. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 

 2.2 Release by Parent. Parent hereby releases, acquits and forever discharges FASL hereunder from
any and all claims or liability for infringement or alleged infringement of any Parent Licensed Patent by performance of acts prior to the date on which such Patent becomes a Parent Licensed Patent that, if performed on or after such date, would be
acts licensed, sublicensed or immunized hereunder. 
  
 3. GRANTS
OF LICENSE 
  
 3.1 Grant by
FASL. Subject to the terms and conditions of this Agreement, FASL hereby grants to Parent a non-exclusive and non-transferable (except pursuant to Section 10.6) license under FASL Licensed Patents: 
  
 3.1.1 to make, have made, use, sell, offer to sell, lease, import or
otherwise dispose of Licensed Products (other than Manufacturing Apparatuses) anywhere in the world; and 
  
 3.1.2 to make, have made and use Manufacturing Apparatuses anywhere in the world, and to sell, offer to sell, lease, import or otherwise dispose of such
Manufacturing Apparatuses anywhere in the world. 
  
 3.2 Grant
by Parent. Subject to the terms and conditions of this Agreement, Parent hereby grants to FASL a non-exclusive and non-transferable (except pursuant to Section 10.6) license under Parent Licensed Patents: 
  
 3.2.1 to make, have made, use, sell, offer to sell, lease, import or
otherwise dispose of Licensed Products (other than Manufacturing Apparatuses) anywhere in the world; and 
  
 3.2.2 to make, have made and use Manufacturing Apparatuses anywhere in the world, and to sell, offer to sell, lease, import or otherwise dispose of such
Manufacturing Apparatuses anywhere in the world. 
  
 3.3
Non-Semiconductor Groups. 
  
 3.3.1 Notwithstanding
anything to the contrary in this Agreement, the rights, licenses and immunities granted by Parent hereunder to FASL (and the definition of Parent Licensed Patents included in such grant) shall exclude Licensed Patents of any Parent Non-Semiconductor
Group. No Parent Non-Semiconductor Group may exercise the rights, licenses and immunities granted hereunder to Parent for Licensed Products, except with respect to Licensed Products that are made by or for the Parent Semiconductor Group or a
Subsidiary sublicensed hereunder. 
  
 3.3.2 Notwithstanding
anything to the contrary in this Agreement, the rights, licenses and immunities granted by FASL hereunder to Parent (and the definition of FASL Licensed Patents included in such grant) shall exclude Licensed Patents of any FASL Non-Semiconductor
Group. No FASL Non-Semiconductor Group may exercise the rights, licenses and immunities granted hereunder to FASL for Licensed Products, except with respect to Licensed Products that are made by or for the FASL Semiconductor Group or a Subsidiary
sublicensed hereunder. 
  

 8 
  

 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as ****. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 

 4. IMMUNITY FOR CUSTOMERS AND USERS

  
 4.1 Grant of Immunity by FASL. The licenses
granted to Parent pursuant to Section 3 shall include immunity for (and FASL hereby covenants not to sue) the resellers, distributors, users and other customers, direct or indirect, of Parent for Licensed Products made, imported, sold, offered for
sale, leased or otherwise disposed of by or for or on behalf of Parent as set forth herein (whether such products are used, imported, sold, offered for sale, leased or otherwise disposed of alone or in combination with other products or services,
although such immunity will not extend to any such combinations or parts of such other products or services other than the Licensed Products). With respect to products made by Parent on a foundry basis where a customer engages Parent as a foundry to
make products for resale in the semiconductor merchant market by such customer based on designs, logic and/or specifications of such customer, the immunities granted to such customer pursuant to this Section 4 shall extend only to any Parent
materials, information or technology supplied to such customer or incorporated in such products, or the process or method used to make such products. For purposes of clarification, the foregoing shall not affect in any way the licenses and
immunities granted to Parent and its resellers, distributors, users and other customers (to the extent such other customers are not engaging Parent as a foundry as described above), direct or indirect, by this Agreement, including Sections 3 and 5
and this Section 4. The sale or other disposition to resellers, distributors, users and other customers, direct or indirect, of products by Parent does not convey any license or immunity, by implication, estoppel, or otherwise, to such resellers,
distributors, users and other customers, direct or indirect, under Patent claims covering combinations of such products with other devices or elements. 
  
 4.2 Grant of Immunity by Parent. The licenses granted to FASL pursuant to Section 3 shall include immunity for (and Parent hereby covenants not to
sue) the resellers, distributors, users and other customers, direct or indirect, of FASL for Licensed Products made, imported, sold, offered for sale, leased or otherwise disposed of by or for or on behalf of FASL as set forth herein (whether such
products are used, imported, sold, offered for sale, leased or otherwise disposed of alone or in combination with other products or services, although such immunity will not extend to any such combinations or parts of such other products or services
other than the Licensed Products). With respect to products made by FASL on a foundry basis where a customer engages FASL as a foundry to make products for resale in the semiconductor merchant market by such customer based on designs, logic and/or
specifications of such customer, the immunities granted to such customer pursuant to this Section 4 shall extend only to any FASL materials, information or technology supplied to such customer or incorporated in such products, or the process or
method used to make such products. For purposes of clarification, the foregoing shall not affect in any way the licenses and immunities granted to FASL and its resellers, distributors, users and other customers (to the extent such other customers
are not engaging FASL as a foundry as described above), direct or indirect, by this Agreement, including Sections 3 and 5 and this Section 4. The sale or other disposition to resellers, distributors, users and other customers, direct or indirect, of
products by FASL does not convey any license or immunity, by implication, estoppel, or otherwise, to such resellers, distributors, users and other customers, direct or indirect, under Patent claims covering combinations of such products with other
devices or elements. 
  

 9 
  

 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as ****. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 

 5. EXTENSION OF LICENSE 
  
 5.1 Right of Parent. Parent shall have the right to grant sublicenses
of the rights, licenses and immunities granted to Parent under Sections 2, 3 and 4, to a Subsidiary of Parent that is subject to control by the Semiconductor Group, but subject to the condition that such Subsidiary grants a license to FASL under its
Subsidiary Licensed Patents, if any. Any such grant-back license shall otherwise be of a scope equivalent to that of Section 3.2. For purposes of clarification, (a) except as set forth in Section 5.2, it is an option, and not an obligation, for a
Subsidiary to grant back such a license, unless and until such Subsidiary elects to be granted a sublicense of such rights, licenses and immunities, and (b) even without obtaining such a sublicense, a Subsidiary of Parent (whether subject to control
by the Semiconductor Group or a Non-Semiconductor Group) may exercise the rights, licenses and immunities granted hereunder to Parent solely for Licensed Products that are made by or for the Semiconductor Group or a Subsidiary of Parent sublicensed
hereunder. 
  
 5.2 Semiconductor Group Subsidiaries.
If requested by FASL, Parent shall cause a Subsidiary actually controlled by the Semiconductor Group of Parent to grant a license to FASL under Section 5.1, in which case such Subsidiary shall be deemed sublicensed pursuant to Section 5.1.

  
 5.3 Right of FASL. FASL shall have the right to grant
sublicenses of the rights, licenses and immunities granted to FASL under Sections 2, 3 and 4, to Subsidiaries of FASL that are subject to control by the FASL Semiconductor Group. 
  
 5.4 No Other Right. A Party shall not have the right to grant sublicenses of the Patents licensed hereunder except as
provided in this Section 5 or in Section 7.1 of the Intellectual Property Contribution and Ancillary Matters Agreement. 
  
 6. ROYALTIES 
  
 6.1 Basic Royalty Payments. In consideration of the licenses set forth in Section 3.2 with respect to Parent Licensed Patents other than Coatue
Licensed Patents, FASL shall pay to Parent the following royalty payments (each a “Basic Royalty Payment”): 
  
 6.1.1 During the ***** year period commencing on the Effective Date, ***** of Net Sales of Licensed Products; 
  
 6.1.2 During the ***** year period commencing on the ***** anniversary of the
Effective Date, ***** of Net Sales of Licensed Products; and 
  
 6.1.3 During the ***** year period commencing on the ***** anniversary of the Effective Date, ***** of Net Sales of Licensed Products. 
  
 FASL shall not owe any royalties on Net Sales of Licensed Products occurring on or after the ***** anniversary of the Effective Date in consideration of the license
hereunder to Parent Licensed Patents. 
  
 6.2 Coatue Royalty
Payments. In consideration of the licenses set forth in Section 3.2 with respect to Coatue Licensed Patents and the license set forth in Section 5 of the Intellectual Property Contribution and Ancillary Matters Agreement, in addition to Basic

  

 10 
  

 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as ****. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 

 
Royalty Payments as set forth in Section 6.1, FASL shall pay to Parent during the period commencing ***** and terminating on *****, ***** of Net Sales of
Coatue Products (each a “Coatue Royalty Payment”). FASL shall not owe any royalties on Net Sales of Coatue Products, other than Basic Royalty Payments as set forth in Section 6.1, occurring on or after ***** in consideration of the
license hereunder to Coatue Licensed Patents. 
  
 6.3
Reports. FASL shall: (a) keep accurate and detailed accounts and records of all Royalty Payments due under this Agreement; and (b) within sixty (60) days after the last day of each Semi-Annual Period, deliver to Parent a statement of all
Royalty Payments due to Parent, if any, during such Semi-Annual Period. 
  
 6.4 Payment Terms. Royalty Payments for Net Sales occurring during each Semi-Annual Period shall be made within sixty (60) days from the end of such Semi-Annual Period. All amounts payable by FASL to Parent shall be paid by wire
transfer of U.S. Dollars in immediately available funds to such financial institution and account number as Parent may designate in writing to FASL. 
  
 6.5 Exchange Rates. In the event of any Net Sales from the sale or other distribution of a Licensed Product by FASL in any currency other than U.S.
Dollars, for purposes of determining the Royalty Payment, FASL shall use the Exchange Rate in effect on the last day of the month in which such sale or other distribution was effected. 
  
 6.6 Late Payments. If FASL fails to make any payment on or before the required payment date, FASL shall be liable for
interest on such payment, for the period commencing on such required payment date and ending on the date such payment is made, at the rate of ten percent (10%) per annum or the maximum amount allowed by Applicable Law, whichever is less. 

 
 6.7 Taxes. In the event that FASL is required by Applicable Law to
withhold any Tax from any amount payable by FASL to Parent hereunder, (a) FASL shall withhold such Tax and remit such withheld amount to the appropriate Governmental Authorities in accordance with Applicable Law and shall promptly report to Parent
the amounts and dates of all such withholdings, and (b) the amount otherwise payable to Parent by FASL hereunder upon which such withholding is based shall be decreased accordingly; provided, that FASL shall in all events provide Parent with five
Business Days advance written notice of the amount of any withholding to be made hereunder. FASL shall promptly furnish Parent with official copies (or certified copies if official copies are not available) of each Tax receipt received from any
Governmental Authority and a copy of any document pertaining to Parent filed with any Governmental Authority (including United States Internal Revenue Service Form 1042-S), and shall furnish Parent with such other documentation relating to any such
deductions or withholdings as may be reasonably requested by Parent. If at any time Parent believes that FASL may in the future adopt withholding practices in respect of Parent that are not in accordance with the requirements of Applicable Law,
Parent shall notify FASL of the basis for its objection to such withholding practices and, if the matter cannot be resolved by agreement, FASL shall refer the issue to an independent law firm of national stature (which shall not be a law firm that
is regularly used by FASL or AMD), which shall advise FASL concerning the legal obligations of FASL in respect of withholding, and thereafter FASL shall act consistently with such advice in matters pertaining to withholding. If FASL acts in
accordance with the advice of such law firm and a Governmental Authority later asserts in 
  

 11 
  

 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as ****. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 

 
writing to any Party that FASL failed to withhold Tax from amounts payable to Parent hereunder at the time and/or in the amounts required by Chapter 3 of the
Code or comparable provisions of other Tax laws in respect of Parent, then Parent shall promptly upon receipt of a copy of such writing accompanied by a written notice from FASL specifying that a payment is required pursuant to this Section 6.7 pay
to such Governmental Authority an amount in full satisfaction of the amount of Taxes so asserted by such Governmental Authority. If Parent does not promptly pay such amount to such Governmental Authority, then, unless Parent provides satisfactory
written evidence of settlement in full of the matter asserted by the Governmental Authority, FASL shall withhold such amount from the next payment(s) to Parent, shall promptly pay such withheld amounts over to such Governmental Authority in payment
of such asserted liability for Taxes. 
  
 6.8 Audit. Parent
may audit the books and records of FASL and its Subsidiaries as may reasonably be required to verify the accuracy and sufficiency of FASL’s payment of Royalty Payments hereunder. Any such audit shall be at Parent’s expense; provided
that, if such audit reveals an underpayment of five percent (5%) or more, FASL shall promptly pay to Parent all costs and expenses of such audit. FASL shall promptly pay Parent the amount of any underpayment revealed by any such audit.
Parent’s rights under this provision, with respect to Royalty Payments paid and payable on Net Sales occurring during each Semi-Annual Period, shall continue for a period of six (6) years after the last day of such Semi-Annual Period.

  
 7. WARRANTIES AND DISCLAIMERS

  
 7.1 Warranties. Subject to Section 10.1, each
Party represents and warrants to the other Party that it has the right, and will continue during the term of this Agreement to have the right, to grant to or for the benefit of the other Party the rights and licenses granted hereunder in accordance
with the terms of this Agreement and such grant of rights and licenses does not, and will not during the term of this Agreement, conflict with the rights and obligations of such Party under any other license, agreement, contract or other
undertaking. 
  
 7.2 Disclaimer. EXCEPT AS OTHERWISE
EXPRESSLY SET FORTH IN ANY TRANSACTION DOCUMENT, NEITHER PARTY MAKES (AND EACH PARTY HEREBY EXPRESSLY DISCLAIMS) ANY REPRESENTATIONS OR WARRANTIES, WHETHER EXPRESS, IMPLIED OR STATUTORY, INCLUDING ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS
FOR A PARTICULAR PURPOSE OR NON-INFRINGEMENT, AND ANY WARRANTIES THAT MAY ARISE FROM COURSE OF PERFORMANCE, COURSE OF DEALING OR USAGE OF TRADE. 
  
 8. LIMITATION OF LIABILITY 
  

TO THE EXTENT PERMITTED BY APPLICABLE LAW, IN NO EVENT SHALL EITHER PARTY BE LIABLE TO THE OTHER PARTY UNDER ANY LEGAL THEORY FOR ANY INDIRECT,
SPECIAL, INCIDENTAL, CONSEQUENTIAL OR PUNITIVE DAMAGES, OR ANY DAMAGES FOR LOSS OF PROFITS, REVENUE OR BUSINESS, EVEN IF SUCH PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. 
  

 12 
  

 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as ****. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 

 9. TERM AND TERMINATION 
  
 9.1 Term. This Agreement will be effective as of the Effective Date,
and will continue in full force and effect until the later to occur of (a) the tenth (10th) anniversary of the
Effective Date, or (b) Parent transferring 100% of its membership interest in FASL or 100% of its economic interest in FASL, regardless of whether such transfer results in the admission of another member, at which time this Agreement shall
terminate, unless earlier terminated as set forth in this Section 9. 
  
 9.2 Termination for Change of Control of Party. Either Party shall have the right to terminate this Agreement, or to invoke the provisions of Section 9.3.3 if this Agreement was previously terminated, in the event the other
Party or its Semiconductor Group undergoes a Change of Control (including a Change of Control in connection with bankruptcy proceedings of such other Party) by giving thirty (30) days’ written notice of termination or invocation to the other
Party, provided that the terminating or invoking Party must exercise such right no later than ninety (90) days after receiving notice of such Change of Control. 
  
 9.3 Effect on Licenses 
  
 9.3.1 Upon termination of this Agreement pursuant to Section 9.1, the rights, licenses and immunities granted by each Party and its Subsidiaries hereunder
shall survive such termination and shall continue until the expiration of the last to expire of the Licensed Patents, subject to Sections 9.2 and 9.3.3. 
  
 9.3.2 Upon termination of this Agreement pursuant to Section 9.2, the rights, licenses and immunities granted by each Party and its Subsidiaries hereunder
shall survive such termination solely under those Licensed Patents that are entitled to an effective filing date that is on or before, and are licensed as of, the Change of Control Date, and shall continue until the expiration of the last to expire
of such Licensed Patents, subject to Sections 9.2 and 9.3.3. 
  
 9.3.3 Upon termination of this Agreement pursuant to Section 9.2 or invocation of the provisions of this Section 9.3.3 pursuant to Section 9.2, the rights, licenses and immunities granted under Circuit Patents to Acquired Party and its
Subsidiaries hereunder shall be limited solely to: 
  
 (a) each Existing Product and Pending Product of Acquired Party and its Subsidiaries sublicensed hereunder as of the Change of Control Date (“Acquired Party Covered Product”); 
  
 (b) each Existing Product and Pending Product of Acquirer as
of the Change of Control Date that would have been in direct competition with an Acquired Party Covered Product if both such products were offered for sale contemporaneously by different Persons (“Acquirer Competitive Product”); and

  
 (c) Successor Products. 
  
 Notwithstanding anything to the contrary, once the rights, licenses and immunities granted
under Circuit Patents to an Acquired Party and its Subsidiaries hereunder have been limited 
  

 13 
  

 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as ****. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 

 
pursuant to this Section 9.3.3, in no event shall such rights, licenses and immunities be subsequently broadened or expanded to cover additional products or
Patents. 
  
 9.4 Effect on Royalties. To the extent that
FASL retains any of the licenses under Parent Licensed Patents other than Coatue Licensed Patents granted by Parent under Sections 3 and 5 following any termination of this Agreement, the obligations of FASL under Section 6.1 shall survive. To the
extent that FASL retains any of the licenses under Coatue Licensed Patents granted by Parent under Sections 3 and 5 following any termination of this Agreement, the obligations of FASL under Section 6.2 shall survive. To the extent that Section 6.1
or Section 6.2 survives, Sections 6.3 through 6.8 shall survive. 
  
 9.5 Continuing Liability. The termination of this Agreement for any reason shall not release either Party from any liability, obligation or agreement which has already accrued at the time of termination. Termination of this Agreement
for any reason shall not constitute a waiver or release of, or otherwise be deemed to prejudice or adversely affect, any rights, remedies or claims, whether for damages or otherwise, which a Party may have hereunder, at law or otherwise, or which
may arise out of or in connection with such termination. 
  
 9.6
Survival. The provisions of Sections 1, 2, 4 (with respect to Licensed Products made, imported, sold, offered for sale, leased or otherwise disposed of prior to termination of the Agreement), 6, 8, 9.2, 9.3, 9.4, 9.5, 9.6 and 10, and any
other sections of this Agreement to the extent expressly provided herein, shall survive any termination of this Agreement. 
  
 10. MISCELLANEOUS 
  
 10.1 Limitation. Nothing contained in this Agreement shall be construed as: 
  
 10.1.1 a warranty or representation by either Party or its Subsidiaries sublicensed hereunder as to the validity,
enforceability or scope of any Licensed Patents; or 
  
 10.1.2
conferring upon either Party or its Subsidiaries sublicensed hereunder any license, right or privilege under any patents, utility models or design patents except the licenses, rights and privileges expressly granted hereunder; or 
  
 10.1.3 a warranty or representation that any acts licensed or sublicensed
hereunder will be free from infringement of patents, utility models, design patents, copyrights, mask work rights or trade secrets other than those Patents under which licenses, rights and privileges have been expressly granted hereunder; or

  
 10.1.4 an obligation of either Party or its Subsidiaries to
file or maintain any patent application, secure any patent or maintain any patent in force; or 
  
 10.1.5 an arrangement to bring or prosecute actions or suits against third parties for infringement or conferring any right to bring or prosecute actions or suits against third parties for infringement; 
  

 14 
  

 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as ****. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 

 10.1.6 conferring any right to use in advertising, publicly or otherwise, any trademark, service mark,
trade name or their equivalent, or any contraction, abbreviation or simulation thereof, of either Party or its Subsidiaries sublicensed hereunder; or 
  
 10.1.7 derogating from or otherwise affecting Parent’s non-competition obligations in Sections 2 and 3 of the Non-Competition Agreement for so long
as such obligations remain in effect. 
  
 10.2 Relationship of
the Parties. In the exercise of their respective rights, and the performance of their respective obligations hereunder, the Parties are, and will remain independent contractors. Nothing in this Agreement will be construed to constitute the
Parties as partners, or principal and agent for any purpose whatsoever. Neither Party will bind, or attempt to bind, the other Party hereto to any contract or other obligation, and neither Party will represent to any third party that it is
authorized to act on behalf of the other Party to this Agreement. 
  
 10.3 Governing Law. This Agreement will be governed by and construed in accordance with the laws of the State of California, United States of America, as applied to agreements among California residents entered into and wholly to be
performed within the State of California (without reference to any choice or conflicts of laws rules or principles that would require the application of the laws of any other jurisdiction). 
  
 10.4 Dispute Resolution. The Parties hereby agree that claims,
disputes or controversies of whatever nature, arising out of, in connection with, or in relation to the interpretation, performance or breach of this Agreement shall be resolved in accordance with the dispute resolution procedures set forth in
Schedule A to the Operating Agreement applied mutatis mutandis. 
  
 10.5 Language. This Agreement is in the English language only, which language shall be controlling in all respects, and all versions hereof in any other language shall be for accommodation only and shall not be
binding upon the Parties. All communications and notices to be made or given pursuant to this Agreement shall be in the English language. 
  
 10.6 Successors and Assigns. Each Party shall have the right (with written notice to the other Party, but without the need to obtain the consent of
the other Party) to assign this Agreement, together with all of its rights and obligations hereunder, to an Acquirer as part of a merger or consolidation of such Party or its Semiconductor Group with or into such Acquirer or a merger of such
Acquirer into such Party, or as part of a sale of all or substantially all of the assets or business of such Party or its Semiconductor Group to such Acquirer, provided that the assigning Party’s right to make such assignment is
contingent and conditioned upon the non-assigning Party being accorded the right to terminate this Agreement or invoke the provisions of Section 9.3.3 following such merger, consolidation or sale of assets or business, as applicable, in accordance
with the terms of Section 9.2; and provided further that such Acquirer assumes all of the assigning Party’s obligations under this Agreement, including the obligation to grant, under all Licensed Patents of the assigning Party and its
Subsidiaries licensed as of the Change of Control Date and all Acquirer Licensed Patents (subject to Section 3.3), the rights, licenses and immunities granted to the non-assigning Party and its Subsidiaries under Sections 2, 3 and 4 (as may be
limited under Sections 9.3.2 and 9.3.3). In addition, each Party shall have the right (with written notice to 
  

 15 
  

 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as ****. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 

 
the other Party, but without the need to obtain the consent of the other Party) to assign this Agreement, together with all of its rights and obligations
hereunder, to a Subsidiary of such Party to which such Party transfers all or substantially all of the assets or business of its Semiconductor Group (for purposes of clarification, such transfer shall not be deemed a Change of Control of such Party
or its Semiconductor Group). Except as expressly provided herein, the rights and obligations hereunder may not be assigned or delegated by a Party without the prior written consent of the other Party. Any purported assignment, sale, transfer,
delegation or other disposition of such rights or obligations by either Party, except as permitted herein, shall be null and void. Subject to the foregoing, this Agreement shall be binding upon and shall inure to the benefit of the Parties and their
respective successors and permitted assigns. Neither Party shall assign its rights under any of its Licensed Patents unless such assignment is made subject to the terms of this Agreement. 
  
 10.7 Entire Agreement; Amendment. This Agreement (including the Schedules hereto) and the other Transaction Documents
constitute the full and entire understanding and agreement between the Parties with regard to the subject matter hereof, and supersede any prior communications, representations, understandings and agreements, either oral or written, between the
Parties with respect to such subject matter; provided, however, that the rights, licenses and immunities granted to the Parties in such prior agreements shall survive the execution of this Agreement and the other Transaction Documents to the
extent set forth in, and in accordance with the terms of, the FASL (Japan) Termination Agreement (including Section 3.6 thereof). This Agreement may not be altered or amended except by a written instrument signed by authorized legal representatives
of both Parties and Fujitsu. Any waiver of the provisions of this Agreement or of a Party’s rights or remedies under this Agreement must be in writing to be effective. Failure, neglect or delay by a Party to enforce the provisions of this
Agreement or its rights or remedies at any time will not be construed and will not be deemed to be a waiver of such Party’s rights under this Agreement and will not in any way affect the validity of the whole or any part of this Agreement or
prejudice such Party’s right to take subsequent action. No single or partial exercise of any right, power or privilege granted under this Agreement shall preclude any other or further exercise thereof or the exercise of any other right, power
or privilege. The rights and remedies provided in this Agreement are cumulative and are not exclusive of any rights or remedies provided by law or any other Transaction Document. 
  
 10.8 Notices and Other Communications. All notices required or permitted under this Agreement shall refer to this
Agreement and will be deemed given: (a) when delivered personally; (b) when sent by confirmed facsimile; (c) five (5) business days after having been sent by registered or certified mail, return receipt requested, postage prepaid; or (d) three (3)
business days after deposit with an internationally recognized commercial overnight carrier specifying next-day delivery, with written verification of receipt. All such notices, requests, demands and other communications shall be addressed as
follows: 
  

 16 
  

 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as ****. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 

 If to FASL: 
  
 FASL LLC 
 c/o Advanced Micro Devices, Inc. 
 One AMD Place 
 M/S 150 
 P.O.
Box 3453 
 Sunnyvale, California 94086 
 Attn: General Counsel 
 Telephone: (408) 749-2202 
 Facsimile: (408) 774-7399 
  
 With a copy to (which shall not constitute notice): 
  
 FASL LLC 
 915 DeGuigne Drive 
 Sunnyvale, California 94086 
 U.S.A. 
 Attention: Chief Executive Officer 
 Telephone: (408) 749-5172 
 Facsimile: (408) 749-2068 
  
 If to AMD: 
  
 Advanced Micro Devices, Inc. 
 One AMD Place 
 Sunnyvale, California 94086 
 U.S.A. 
 Attn: General Counsel 
 Telephone: +1 (408) 749-2202 
 Facsimile: +1 (408) 774-7399 
  
 With a copy to (which shall not constitute notice):

  
 Advanced Micro Devices, Inc. 
 5204 East Ben White Boulevard 
 Mail Stop 563 
 Austin, Texas 78741 
 Attn: Vice President, Intellectual Property 
 Telephone: +1 (512) 602-0148 
 Facsimile: +1 (512) 602-4932 
  
 or to such other address or facsimile number as a Party may have specified to the other Party
in writing delivered in accordance with this Section 10.8. 
  
 10.9 Expenses. Except as otherwise expressly set forth in this Agreement, each Party will bear its own costs and expenses, including fees and expenses of legal counsel and other representatives used or hired in connection with
the transactions described in this Agreement. 
  

 17 
  

 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as ****. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 

 10.10 Severability. If any provision in this Agreement is found or held to be invalid or
unenforceable, then the meaning of such provision will be construed, to the extent feasible, so as to render the provision enforceable, and if no feasible interpretation would save such provision, it will be severed from the remainder of this
Agreement which will remain in full force and effect unless the severed provision is essential and material to the rights or benefits received by any Party. In such event, the Parties will use their respective best efforts to negotiate, in good
faith, a substitute, valid and enforceable provision or agreement which most nearly effects the Parties’ intent in entering into this Agreement. 
  
 10.11 Construction. This Agreement shall be deemed to have been drafted by both Parties and, in the event of a dispute, no Party hereto shall be
entitled to claim that any provision should be construed against any other Party by reason of the fact that it was drafted by one particular Party. 
  
 10.12 Execution. This Agreement may be executed in counterparts, each of which so executed will be deemed to be an original and such
counterparts together will constitute one and the same agreement. Execution and delivery of this Agreement by exchange of facsimile copies bearing the facsimile signature of a Party shall constitute a valid and binding execution and delivery of this
Agreement by such Party. 
  
 10.13 Confidentiality of Terms.
Neither Party shall disclose the terms of this Agreement to any third parties, except that either Party may disclose to third parties the existence of this Agreement and may disclose the terms of this Agreement to the extent reasonably
necessary, in confidence, to its legal counsel, accountants, and banks and their advisors, and to its present or future financing sources for, potential investors in, and potential successors to, all or any portion of the assets or business of such
Party. 
  
 [Remainder of page intentionally left blank.]

  
  

 18 
  

 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as ****. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 

 IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed and delivered by their
respective duly authorized representatives as of the date first above written. 
  

	ADVANCED MICRO DEVICES, INC.	 	 	 	FASL LLC
					
	By:	 	 /s/ Thomas M. McCoy

	 	 	 	By:	 	 /s/ Thomas M. McCoy

	 Name:
	 	Thomas M. McCoy	 	 	 	 Name:
	 	Thomas M. McCoy
	 Title:
	 	Senior Vice President, General Counsel	 	 	 	 Title:
	 	Manager

  

 S-1 
  

 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as ****. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission.AMD Distribution Agreement

 Exhibit 10.56 
  
 AMD DISTRIBUTION AGREEMENT 
  

JUNE 30, 2003 
  

 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as ****. A complete version of the exhibit has been filed separately with the securities and Exchange Commission. 

 AMD DISTRIBUTION AGREEMENT 
  
 THIS DISTRIBUTION AGREEMENT (this “Agreement”) is made and entered into as of June 30, 2003 (the
“Effective Date”), by and between FASL LLC, a Delaware limited liability company (“FASL”), and Advanced Micro Devices, Inc., a Delaware corporation (“AMD”). FASL and AMD are hereinafter also
referred to as the “Parties” and individually as a “Party.” 
  
 RECITALS 
  
 WHEREAS, pursuant to the Amended and Restated Limited Liability Company Operating Agreement, dated June 30, 2003 (the “LLC Operating Agreement”), among AMD, AMD Investments, Inc., a Delaware corporation
(“AMDI”), Fujitsu Limited, a Japanese corporation (“Fujitsu”), and Fujitsu Microelectronics Holding, Inc., a Delaware corporation (“FMH”), and the Contribution and Assumption Agreement (the
“Contribution Agreement”), among AMD, AMDI, Fujitsu, FMH and FASL, AMD and Fujitsu have formed FASL for the purpose of designing, manufacturing and marketing flash memory products; and 
  
 WHEREAS, as part of such joint venture arrangement, AMD and Fujitsu
have agreed that FASL will appoint AMD and Fujitsu as FASL’s sole initial distributors of Products (as defined below). 
  
 NOW, THEREFORE, in consideration of the mutual representations, warranties, covenants and other terms and conditions contained herein, FASL and AMD
agree as follows: 
  
 AGREEMENT 
  
 1. DEFINITIONS; INTERPRETATION 
  
 1.1 Capitalized but Undefined Terms. Capitalized terms used in this
Agreement but not defined herein shall have the meaning ascribed to such terms in the LLC Operating Agreement. 
  
 1.2 Terms Defined in this Agreement. The following terms when used in this Agreement shall have the following definitions: 
  
 1.2.1 “Action Plan” has the meaning set forth in Section
14.2.1. 
  
 1.2.2 “Affiliate” is defined in the
LLC Operating Agreement. 
  
 1.2.3 **** means a Customer listed as
such on Schedule 2.1. 
  
 1.2.4 “AMD
****Customer” means a Customer listed as such on Schedule 2.1. 
  

 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as ****. A complete version of the exhibit has been filed separately with the securities and Exchange Commission. 

 1.2.5 “AMD **** Customers” means the Customers set forth in Section A of Schedule
1.2.5 and such other Customers that are specified as AMD **** Customers in accordance with Section B of Schedule 1.2.5. 
  
 1.2.6 “AMD **** Customer” means a Customer listed as such on Schedule 2.1. 
  
 1.2.7 “AMD Territory” means the Americas and Europe.

  
 1.2.8 “AMD **** Customer” means,
collectively, the AMD **** Customers and the AMD **** Customers. 
  
 1.2.9 “Americas” means the countries and territories of North America, Central America and South America. 
  
 1.2.10 “Best Efforts” means the efforts that a prudent Entity or person desiring to achieve a particular result would use in order to
achieve such result reasonably expeditiously. An obligation to use “Best Efforts” does not require the Entity or person subject to such obligation to take actions that would result in a materially adverse change in the benefits to such
Entity or person of this Agreement. 
  
 1.2.11 “Channel
Partner” means any Entity other than an AMD Subsidiary who is appointed by AMD as a sub-distributor or sales representative, pursuant to a written agreement between AMD and such Entity in accordance with Section 5.2. A list of Channel
Partners as of the Effective Date is set forth in Schedule 1.2.11. ****. 
  
 1.2.12 “Claims” is defined in Section 19. 
  
 1.2.13 “Combined Product” means any Product that contains both (a) FASL Content, and (b) components or products manufactured by any other Entity, which components or products do not constitute FASL
Content. 
  
 1.2.14 “Confidential Information”
has the meaning set forth in Section 16.1. 
  
 1.2.15
“Customer” means an Entity, other than AMD in its capacity as distributor hereunder, that purchases Products, but excluding Channel Partners. 
  

1.2.16 “Custom Product” means any Product that has sufficiently unique attributes that it may only be sold to a single Customer or to
a limited number of Customers. In addition, if a Product is being discontinued or has been discontinued on a general basis, as set forth in Section 10.2 below, but may still be made available to specific Customers, then it too shall be considered a
Custom Product. FASL will identify all Custom Products as such in FASL’s then-current Quarterly price list or other reasonable form of communication to AMD, including an end-of-life notice, if applicable. 
  
 1.2.17 “Disclosing Party” has the meaning set forth in
Section 16.1. 
  

 2 
  

 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as ****. A complete version of the exhibit has been filed separately with the securities and Exchange Commission 

 1.2.18 “Documentation” means any and all documents or materials, whether in printed form
or in any electronic form or media, that relate to Products and are provided by FASL to AMD hereunder, including marketing materials and brochures, manuals, published Product price lists and Product specifications, but expressly excluding documents
that constitute Confidential Information of FASL. 
  
 1.2.19
“Entity” means a corporation, partnership, limited liability company, unincorporated organization, business association, firm, joint venture or other legal entity. 
  
 1.2.20 “Europe” means the countries and territories of Europe, as listed on Schedule 1.2.20.

  
 1.2.21 “FAE” means a field applications
engineer. 
  
 1.2.22 “FASL Board” means the Board
of Managers of FASL. 
  
 1.2.23 “FASL Content”
means components or products manufactured by FASL or a FASL Subsidiary, or components or products specifically manufactured by any other Entity, including AMD or Fujitsu or any third party subcontractor or foundry, on behalf of FASL or a FASL
Subsidiary at FASL’s or the FASL Subsidiary’s direction and based on (a) technology or intellectual property owned by FASL, or which FASL otherwise has the right to use, or (b) designs provided by FASL, which designs are proprietary to
FASL or a third party licensor of FASL. 
  
 1.2.24 “FASL
Content Only Product” or “FCO Product” means any Product that contains only FASL Content. 
  
 1.2.25 [Intentionally omitted.] 
  
 1.2.26 “Force Majeure” has the meaning set forth in Section 21.9.1. 
  
 1.2.27 “Forecast” has the meaning set forth in Section 4.1. 
  
 1.2.28 “Forecasted Product Requirements” has the meaning set
forth in Section 4.1. 
  
 1.2.29 **** means a Customer listed as
such on Schedule 2.1. 
  
 1.2.30 “Fujitsu ****
Customer” means a Customer listed as such on Schedule 2.1. 
  
 1.2.31 “Fujitsu **** Customers” means the Customers set forth in Section A of Schedule 1.2.31 and such other Customers that are specified as Fujitsu **** Customers in accordance with Section B
of Schedule 1.2.31. 
  
 1.2.32 “Fujitsu ****
Customer” means a Customer listed as such on Schedule 2.1. 
  

 3 
  

 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as ****. A complete version of the exhibit has been filed separately with the securities and Exchange Commission 

 1.2.33 “Fujitsu Territory” means Japan. 
  
 1.2.34 “Fujitsu ****” means, collectively, the Fujitsu ****
Customers and the Fujitsu **** Customers. 
  
 1.2.35 **** means a
Customer listed as such on Schedule 2.1. 
  
 1.2.36
“Guidelines” has the meaning set forth in Section 6.4. 
  
 1.2.37 “INCOTERMS 2000” means the International Rules for the Interpretation of Trade Terms, published by the International Chamber of Commerce in the year 2000. 
  
 1.2.38 “Intellectual Property Rights” means, on a world-wide basis, any and all now known or existing, or
hereafter known or existing, tangible and intangible (a) rights associated with works of authorship, including copyrights, moral rights and mask-works, (b) rights associated with trademarks, service marks, trade names, logos and similar rights, (c)
trade secret rights, (d) rights in patents, designs and algorithms and other industrial property rights, (e) rights in domain names; (f) all other intellectual and industrial property rights of every kind and nature and however designated, whether
arising by operation of law, contract, license or otherwise, and (f) all registrations, applications, renewals, extensions, continuations (including continuations in part), divisions, reexaminations or reissues thereof now or hereafter existing,
made or in force (including any rights in any of the foregoing). 
  
 1.2.39 “Joint Territory” means anywhere in the world other than the AMD Territory and the Fujitsu Territory. 
  
 1.2.40 “Leads” has the meaning set forth in Section 11.4. 
  
 1.2.41 “Marketing Plan” has the meaning set forth in Section 11.1.2. 
  
 1.2.42 “Ownership Interest” means the percentage interest of
FASL common membership interests then held collectively by AMD and its Subsidiaries, divided by all then issued and outstanding FASL common membership interests. 
  
 1.2.43 “PRC” means the People’s Republic of China. 
  
 1.2.44 “Product Distribution Center” has the meaning set
forth in Section 7.1. 
  
 1.2.45 “Production
Volume” means, for a particular Technology for a particular Quarter, FASL’s projected volume of Wafer Outputs for such Technology during such Quarter, as determined by FASL at the beginning of the relevant Quarter using FASL’s
then-current QBP for such Quarter. 
  
 1.2.46
“Product” means any finished product of FASL. 
  
 1.2.47 “Purchase Order” has the meaning set forth in Section 3.1. 
  

 4 
  

 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as ****. A complete version of the exhibit has been filed separately with the securities and Exchange Commission 

 1.2.48 “Purchase Price” means the price per Product at which FASL shall sell such
Product to AMD in accordance with Section 12. 
  
 1.2.49
“Q0” has the meaning set forth in Section 4.2.3. 
  
 1.2.50 “Q1” has the meaning set forth in Section 4.2.3. 
  
 1.2.51 “Q2” has the meaning set forth in Section 4.2.3(b). 
  
 1.2.52 “Q3” has the meaning set forth in Section 4.2.3(c). 
  
 1.2.53 “Quarter” means a FASL fiscal quarter. 
  
 1.2.54 “Receiving Party” has the meaning set forth in Section 16.1. 
  
 1.2.55 “RSP” has the meaning set forth in Section 12.1.

  
 1.2.56 “Standard Product” means any Product
that is not a Custom Product. FASL will identify all Standard Products as such in FASL’s then-current Quarterly price list. 
  
 1.2.57 “Stocking Channel Partner” means a Channel Partner that is designated as such by AMD pursuant to Section 5.3.3. 
  
 1.2.58 “Subsidiary” is defined in the Contribution
Agreement. 
  
 1.2.59 “Technology” means each
process technology used by FASL in the production of Products. A list of Technologies as of the Effective Date is set forth in Schedule 1.2.59. FASL will provide AMD with an updated Schedule 1.2.59 or other reasonable form of notice
from time to time whenever it adds a new Technology, or whenever it decides to no longer produce Products using a then-existing Technology. 
  
 1.2.60 “Term” has the meaning set forth in Section 20.1. 
  
 1.2.61 “Trademarks” means any trademarks, trade names, service marks and logos used by FASL in connection
with Products, including those marks, names and logos set forth in Schedule 1.2.61 attached hereto. 
  
 1.2.62 “Transition Plan” has the meaning set forth in Section 2.1.4. 
  
 1.2.63 “VAT” has the meaning set forth in Section 12.8. 
  
 1.2.64 “Wafer Output” means a semiconductor wafer
manufactured by or for FASL for a specific Technology. 
  
 1.2.65
“Warranty Period” has the meaning set forth in Section 15.1. 
  

 5 
  

 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as ****. A complete version of the exhibit has been filed separately with the securities and Exchange Commission 

 1.3 Interpretation. 
  
 1.3.1 Certain Terms. The words “hereof,” “herein,” “hereunder” and similar words refer
to this Agreement as a whole and not to any particular provision of this Agreement. The term “including” is not limited and means “including without limitation.” 
  
 1.3.2 Section References; Titles and Subtitles. Unless otherwise noted, all references to Sections, Schedules and
Exhibits herein are to Sections, Schedules and Exhibits of this Agreement. The titles, captions and headings of this Agreement are inserted for convenience of reference only and are not intended to be a part of or to affect the meaning or
interpretation of this Agreement. 
  
 1.3.3 Reference to
Entities, Agreements, Statutes. Unless otherwise expressly provided herein, (a) references to an Entity include its successors and permitted assigns, (b) references to agreements (including this Agreement) and other contractual instruments shall
be deemed to include all subsequent amendments, restatements and other modifications thereto or supplements thereof and (c) references to any statute or regulation are to be construed as including all statutory and regulatory provisions
consolidating, amending, replacing, supplementing or interpreting such statute or regulation. 
  
 2. APPOINTMENT; GRANT OF RIGHTS 
  
 2.1 Grant of Distribution Rights; Transitional Support.  
  
 2.1.1 Grant of Rights. Subject to the terms and conditions of this Agreement, FASL grants to AMD the right to market,
sell and otherwise distribute Products during the Term (a) in the AMD Territory and in the Joint Territory ****. No other grant of distribution rights to AMD is implied by this Agreement. 
  
 2.1.2 Transitional Support. 
  

(a) **** 
  
 (i) **** 
  
 (ii) **** 
  
 (iii) **** 
  
 (b) **** 
  
 (i) **** 
  
 (ii) **** 
  
 (iii) **** 
  

 6 
  

 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as ****. A complete version of the exhibit has been filed separately with the securities and Exchange Commission 

 2.1.3 **** 
  
 2.1.4 **** 
  
 2.2 **** 
  
 2.2.1 **** 
  
 2.2.2 **** 
  
 2.2.3 **** 
  
 2.3 AMD Obligations and Restrictions.  
  
 2.3.1 Best Efforts. AMD shall use its Best Efforts to promote the sale of Products in the AMD Territory. In light of the foregoing, the application
of the provisions of Section 2306(2) of the California Commercial Code to the Parties is hereby excluded. 
  
 2.3.2 **** 
  
 2.3.3 **** 
  
 2.3.4 **** 
  
 3. ORDERING; SHIPPING 
  
 3.1 Orders. AMD will accept purchase orders for Products from Customers and Channel Partners in accordance with its customary practices. To purchase Product(s) from FASL, AMD shall issue purchase orders
(“Purchase Orders”), which shall specify the Purchase Order number, type and quantity of Product(s) ordered, Purchase Price (and the **** by the **** or ****, but only if **** is **** the **** for the****), place(s) of delivery
(which shall be the location identified in the relevant Customer or Channel Partner purchase order issued to AMD), and delivery date(s). These Purchase Orders may take the form of electronic submissions in a mutually-acceptable format (including
submissions currently referred to as “B+B+B files”) so long as they contain the same information specified above for Purchase Orders, even if such submissions may not be referred to specifically as “purchase orders” when
transmitted. AMD shall place each Purchase Order with FASL sufficiently in advance of the delivery date to allow for FASL’s Product delivery lead times, as set forth in FASL’s most recent lead time report provided to AMD. FASL shall accept
any Purchase Order submitted by AMD to the extent that such Purchase Order (a) is within the Product allocation assured to AMD in accordance with Section 4.2, (b) conforms to the foregoing lead times, and (c) does not provide for a “ship
to” location, Customer or Channel Partner that is inconsistent with AMD’s distribution rights hereunder. FASL will not accept any order to purchase Products under this Agreement from any Entity or person other than AMD without AMD’s
prior written consent. ****. FASL shall not withhold acceptance of any Purchase Order for Custom Products on a basis that provides AMD less favorable treatment than any other FASL distributor or sales representative submitting 
  

 7 
  

 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as ****. A complete version of the exhibit has been filed separately with the securities and Exchange Commission 

 orders for similar quantities of the same or similar Custom Products; provided that any pre-existing commitments
to any distributor may take precedence over any new commitments for Custom Products so long as FASL makes such determinations on a commercially reasonable and non-discriminatory basis. FASL shall notify AMD as soon as possible if FASL believes that
a Purchase Order for either Standard Products or Custom Products does not meet the foregoing requirements for acceptance by FASL. ****. 
  
 3.2 Cancellations. AMD may cancel any Purchase Order or portion thereof for Standard Products, without charge, upon written notice to FASL at least
**** prior to the applicable delivery date. FASL will determine cancellation policies, procedures and charges with respect to Custom Products, and with respect to Standard Products where notice of cancellation is given less than **** prior to the
applicable delivery date, in advance of AMD’s placement of the applicable Purchase Order and will inform all distributors of such cancellation policies and apply such policies to all distributors, although the parties acknowledge that
exceptions may be made on a case-by-case basis to address particular Customer situations. The Parties will discuss in good faith any cancellations of delivery of Custom Products, or of Standard Products where notice of cancellation is given less
than **** prior to the applicable delivery date, requested by AMD, but the final determination will be FASL’s. 
  
 3.3 Reschedules. AMD may reschedule the delivery of any Purchase Order or portion thereof for Standard Products, without charge, one time only,
upon notice to FASL at least **** prior to the applicable delivery date. Standard Product reschedules may be made less than **** prior to the applicable delivery date, but only upon the agreement of FASL. Any reschedules on less than **** prior
notice shall be subject to reschedule fees payable to FASL in an amount set by FASL in advance of AMD’s placement of the applicable Purchase Order. FASL will also determine reschedule policies, procedures and rights and charges with respect to
Custom Products in advance of AMD’s placement of the applicable Purchase Order. FASL will inform all distributors of its reschedule policies in respect of Standard Products and Custom Products and apply such policies to all distributors
although the parties acknowledge that exceptions may be made on a case-by-case basis to address particular Customer situations. The Parties will discuss in good faith any rescheduling of delivery of Custom Products, or of Standard Products where
notice of rescheduling is given less than **** prior to the applicable delivery date, requested by AMD, but the final determination will be FASL’s. 
  
 3.4 Shipping. FASL shall notify AMD at the time of shipment as to the quantity of Product(s) shipped and the specific shipping information.
Shipping quantities may not vary from those established by the Purchase Order unless otherwise mutually agreed upon in writing by the Parties. FASL shall deliver the ordered Product by the applicable delivery date(s), provided that FASL may
not deliver such Product earlier than the delivery date specified in the applicable Purchase Order. Upon a bona fide, reasonable, ****, AMD may specify that **** and if FASL has agreed in advance for **** that a particular shipment—or shipments
in general ****—will be ****, then in the event that any ****, AMD may direct FASL **** by AMD and FASL ****. FASL shall ship the ordered Product(s) to the delivery address(es) set forth in the applicable Purchase Order. 
  

 8 
  

 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as ****. A complete version of the exhibit has been filed separately with the securities and Exchange Commission 

 3.5 Title and Risk of Loss. 
  
 3.5.1 Shipment from FASL Facility Directly to Customers or Stocking Channel Partners. Delivery of Products from any
FASL facility directly to Customers or Stocking Channel Partners, or to AMD’s ****, shall be **** in accordance with INCOTERMS 2000, unless otherwise agreed in writing by the Parties, and title and risk of loss shall pass from FASL to AMD ****,
which shall be ****, a **** or a ****. 
  
 3.5.2 Shipment from
Product Distribution Centers. Delivery of Products from any Product Distribution Center to a Customer or a Stocking Channel Partner, or to AMD’s ****, shall be **** in accordance with INCOTERMS 2000, unless otherwise agreed by the Parties,
and title and risk of loss shall pass from FASL to AMD **** at ****, in accordance with ****, as interpreted in accordance with INCOTERMS 2000. Without limiting the foregoing, AMD will bear **** attributable to **** from the **** to a ****. FASL
will bear **** to ship Products directly from FASL, a FASL Subsidiary or a FASL subcontractor facility to the Product Distribution Center, the AMD Sub ****. 
  
 4. FORECASTS; PRODUCT ALLOCATIONS 
  
 4.1 Forecasts. AMD working together with FASL shall, on or before the end of the last week of the first month of each
Quarter, provide FASL with a **** forecast (a “Forecast”) setting forth AMD’s projected Product needs for each of the five (5) Quarters following such Quarter (“Forecasted Product Requirements”). Each Forecast
will be organized by FASL on a Technology-by-Technology basis, and will contain a forecast for each Product within a particular Technology. AMD’s initial Forecast is attached hereto as Schedule 4.1. 
  
 4.2 Short-Supply Guaranteed Allocation. 
  
 4.2.1 Allocation. Subject to Section 4.2.3 below, in the event that,
in any Quarter, FASL does not produce enough wafers within a Technology to meet the total orders for Product falling within such Technology issued by AMD and Fujitsu, FASL will allocate its wafer fabrication and assembly, test and package Production
Volume for such Technology as follows: 
  
 (a) to AMD, **** of
Production Volume for such Products for such Quarter; 
  
 (b) to
Fujitsu, **** of Production Volume for such Products for such Quarter; and 
  
 (c) ****. 
  
 4.2.2 ****

  
 (a) **** 
  

 9 
  

 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as ****. A complete version of the exhibit has been filed separately with the securities and Exchange Commission 

 (b) **** 
  
 (c) **** 
  
 4.2.3 **** 
  
 (a) **** 
  
 (b) **** 
  
 (c) **** 
  
 4.3 FASL Adjustments to Production Volume. Notwithstanding anything to the contrary in this Section 4, FASL shall use all commercially reasonable
efforts to increase or reduce, as applicable, Production Volume to reflect AMD’s Forecasted Product Requirements and Fujitsu’s forecasted product requirements. **** 
  
 4.4 Additional Capacity. 
  
 4.4.1 FASL Adding Capacity. In the event that FASL adds additional production capacity that is not contemplated by the ****, AMD, FASL and Fujitsu
shall negotiate, in good faith, and agree as to how additional Production Volume generated therefrom shall be shared among the parties **** 
  
 4.4.2 Request for Additional Capacity from AMD. **** 
  
 4.4.3 Request for Additional Capacity from Fujitsu. **** 
  

5. SUBSIDIARIES AND CHANNEL PARTNERS 
  
 5.1 Right to Appoint Subsidiaries. FASL hereby grants to AMD the right during the Term to appoint any Subsidiary as a
subdistributor or sales representative of AMD, provided that such appointment is on terms and conditions consistent with this Agreement, including that any such Subsidiary will abide by **** 
  
 5.2 **** 
  
 5.3 Channel Management. With respect to its Channel Partners, AMD will: 
  
 5.3.1 use commercially reasonable efforts to enforce the terms and
conditions of its agreements with its Channel Partners, including the sub-distributor obligations set forth in Schedule 5.3.1; 
  
 5.3.2 provide each Channel Partner with commercially reasonable field sales and field applications support, and with commercially reasonable assistance in
connection with each such Channel Partner’s promotion and sale of Products; provided that AMD shall have no obligation to provide field applications support in the Fujitsu Territory; 
  

 10 
  

 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as ****. A complete version of the exhibit has been filed separately with the securities and Exchange Commission 

 5.3.3 use commercially reasonable efforts to ensure that each Channel Partner designated as a
“stocking” Channel Partner by AMD (which designation shall be made by AMD in its sole discretion) maintains a representative minimum level of Product inventory in order to ensure timely off-the-shelf delivery of Products to Customers;

  
 5.3.4 use commercially reasonable efforts to ensure that each
Channel Partner complies with FASL’s distribution policies and procedures; and 
  
 5.3.5 use Best Efforts to ensure its Channel Partners have the ability to successfully promote Products in the regions in which they are actively pursuing Product sales. 
  
 5.4 Stock Rotations. AMD shall have the right to accept Product stock
rotation returns from its Stocking Channel Partners in accordance with FASL’s **** stock rotation policies, provided that AMD shall not permit any Stocking Channel Partner to return **** Products held as inventory by such Stocking
Channel Partner, based upon net shipments and in accordance with the time frames and procedures specified by FASL. FASL will notify AMD in advance of AMD’s placement of the applicable Purchase Orders of its stock rotation policies and agrees to
provide AMD ****. If AMD accepts Product stock rotation returns from any Stocking Channel Partner, AMD shall promptly return such Products to FASL. AMD will, on a Quarterly basis, provide FASL with a written report regarding stock rotation returns
by AMD to FASL, such written report identifying the Stocking Channel Partner that returned Products and specifying the Products returned (by Product number, and amount). On a Quarterly basis, FASL shall perform an inspection and audit of the
returned Products, and in the normal course of business ****. In order to pass inspection, all Products returned in accordance with this Section 5.4 must be in their original, unopened factory-sealed unit packaging containers and otherwise
unaltered. 
  
 5.5 Termination of a Channel Partner. Upon
termination of a Channel Partner relationship, AMD will promptly update Schedule 1.2.11 and, as applicable and if directed by FASL, ****. If so requested by FASL, AMD will ****. 
  
 6. TRADEMARK LICENSE AND RESTRICTIONS; MAINTENANCE;
DOCUMENTATION 
  
 6.1 License. Subject
to the terms and conditions of this Agreement, FASL hereby grants to AMD a non-exclusive, royalty-free, fully paid up license (including the right to grant sublicenses), during the Term, to use and display the Trademarks in the AMD Territory and
Joint Territory, and anywhere else in the world in connection with ****, in all cases solely in connection with the marketing, promotion, advertisement, sale and distribution of Products as expressly permitted herein, and in connection with
AMD’s obligations set forth in Sections 5, 9 and 11. AMD shall not have the right to use the Trademarks to form combination marks with other trademarks, service marks, trade names, designs and logos. 
  
 6.2 No Additional Rights. AMD shall not use any other trademark or
service mark confusingly similar to the Trademarks without the prior written approval of FASL. AMD understands and agrees that (a) as between the Parties, FASL is the sole owner of all right, title and interest in and to the Trademarks, (b) the use
of any Trademark in connection with this Agreement shall not create in AMD any right, title or interest in or to the Trademarks, and (c) all 
  

 11 
  

 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as ****. A complete version of the exhibit has been filed separately with the securities and Exchange Commission 

 such use and goodwill associated therewith shall inure solely to the benefit of FASL. AMD shall not challenge the
validity of the Trademarks, nor shall AMD challenge or take any action inconsistent with FASL’s ownership of the Trademarks or the enforceability of FASL’s rights therein, unless the Trademark in question is used (without violation of
FASL’s rights) or owned by AMD (whether or not such Trademark is registered in any particular jurisdiction) prior to FASL’s adoption or use of the Trademark, as demonstrated by AMD. 
  
 6.3 Registration. FASL shall retain the exclusive right to apply for
and obtain registrations for the Trademarks throughout the world. AMD, upon FASL’s reasonable request, agrees to reasonably cooperate with FASL’s preparation and filing of any applications, renewals or other documentation necessary or
useful to protect FASL’s Intellectual Property Rights in the Trademarks, including by providing FASL with brochures, manuals, advertisements and other materials concerning Products. Any cooperation that AMD provides in accordance with this
Section 6.3 shall be at FASL’s sole cost, provided that such costs are reasonably incurred. 
  
 6.4 Quality Control. All use of the Trademarks shall be in accordance with the FASL trademark guidelines attached hereto as Exhibit 6.4, as
may be reasonably amended from time to time by FASL upon reasonable prior written notice to AMD (“Guidelines”), provided that the Guidelines shall apply to all distributors. AMD shall not use the Trademarks in any manner other than
expressly authorized by this Agreement. From time to time upon FASL’s request, AMD shall submit to FASL samples of all AMD materials bearing the Trademarks. If FASL discovers any use of the Trademarks inconsistent with the Guidelines on any
such submitted samples, and delivers to AMD a writing describing in reasonable detail the improper use, AMD shall promptly cease or remedy such use. 
  
 6.5 Documentation. Subject to the terms and conditions of this Agreement, FASL grants to AMD a non-exclusive, royalty-free, fully paid up license
(including the right to grant sublicenses), during the Term, to use, display, translate, modify to make consistent with in its own documentation, copy and otherwise reproduce and distribute (either on its own, or in conjunction with, or as
incorporated in AMD product documentation) the Documentation in the AMD Territory and the Joint Territory, and anywhere in the world in connection with **** and AMD ****, solely in connection with the marketing, promotion, advertisement, sale and
other distribution of Products as expressly permitted herein, and in connection with AMD’s obligations set forth in Sections 5, 9 and 11. Notwithstanding the foregoing, AMD may not modify the Documentation in a manner that misrepresents the
Products. 
  
 7. PRODUCT DISTRIBUTION
CENTERS 
  
 7.1 Product Distribution
Centers. **** will set aside physical space reasonably acceptable to **** in one of the storage or warehouse facilities it owns or leases in Europe for **** to use as a storage and shipping facility for Products (the “Product
Distribution Center”). The size of space **** for the Product Distribution Center shall be agreed upon by the Parties in writing. To the extent feasible, **** shall maintain the Product Distribution Center apart from the space ****. The
Product Distribution Center will be staffed by **** employees or agents, or by **** Subsidiary employees or agents, who shall be granted unlimited access to the Product Distribution Center, but who shall be under the general administrative
supervision of **** for 
  

 12 
  

 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as ****. A complete version of the exhibit has been filed separately with the securities and Exchange Commission 

 site management at the applicable facility. Notwithstanding anything to the contrary in the foregoing, **** and ****
Subsidiary employees and agents shall, and **** or a **** Subsidiary, as applicable, shall cause it employees and agents to: (a) not interfere with **** activities at the **** facilities housing the Product Distribution Center; (b) comply with ****
then-current workplace rules and procedures, as provided by **** to **** from time to time; and (c) take such other action or follow such other procedures as reasonably requested by ****. FASL shall retain title and risk of loss with respect to
Products stored in Product Distribution Center, and, as between the Parties, title and risk of loss shall pass to AMD only in accordance with Section 3.5.2. The Parties currently anticipate that it will not be possible to establish the Product
Distribution Center on or before the Effective Date; the Parties will use Best Efforts to establish the Product Distribution Center as soon as possible after the Effective Date, but in any event will do so no later than January 1, 2004. 

 
 7.2 Product Distribution Center Operating Costs. **** shall provide
use of Product Distribution Center space ****, and ****. Notwithstanding anything to the contrary in the foregoing, **** shall not be responsible for any costs or expenses relating to **** or the **** Subsidiary’s operation of the Product
Distribution Center, including costs relating to the **** or **** Subsidiary employees and/or agents working in the Product Distribution Center, and administrative expenses incurred by **** or a **** Subsidiary in connection with maintaining and
tracking Product inventory and packaging and shipping Products. 
  
 7.3 Consignment Warehouses. Upon the agreement of the Parties, and without limiting Section 2.3.4, AMD may maintain an agreed level of Product inventory in one or more of its consignment warehouses.****; provided, however,
that with respect to Products maintained at ****, title and risk of loss shall pass to AMD upon shipment of such Products from a FASL facility or the Product Distribution Center, and in accordance with Section 3.5. Any such inventory shall be
maintained by AMD employees and at no cost to FASL. FASL will bear shipping costs for shipping Products to a consignment warehouse; AMD will bear shipping costs for shipping Products from a consignment warehouse. AMD will report on the amount and
status of any such inventory from time-to-time as reasonably requested by FASL. Without limiting the foregoing, AMD agrees to use Best Efforts to provide FASL as soon as it may be practicable daily point-of-sales reports in a format and including
the information reasonably designated by FASL regarding all such inventory on a consignment warehouse-by-consignment warehouse basis, providing the same types of information as specified in Schedule 7.3. Payments for Products held by AMD in
accordance with this Section 7.3 shall be made within **** from the date of shipment of such Products to the applicable Customer or Channel Partner. An initial list of consignment warehouses is set forth in Schedule 7.3; AMD will update such
list by reasonable form of notice to FASL if it adds a consignment warehouse location or ceases to use an existing location as a consignment warehouse. 
  
 8. VENDOR MANAGED INVENTORY PROGRAMS 
  
 **** 
  
 9. CUSTOMER SUPPORT RESPONSIBILITIES 
  

 13 
  

 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as ****. A complete version of the exhibit has been filed separately with the securities and Exchange Commission 

 9.1 **** AMD will maintain **** in order to better enable AMD ****. AMD will provide FASL with ****, to
better enable FASL****. FASL shall have no right to use, and shall not use, any ****. Information obtained by FASL from AMD with regard to AMD’s independent sales activities, Product pricing or allocation decisions shall be subject to the
obligations set forth in Section 16, and shall not be disclosed to Fujitsu or to any other Entity or person, except as otherwise expressly permitted hereunder. 
  

9.2 Post-Sale Applications Support. AMD and FASL will provide reasonable field applications support to Customers that are designing in Products.
Upon FASL’s reasonable request, AMD shall dedicate a reasonable number of FAEs to any region in the Joint Territory, on terms and conditions to be agreed in writing by the Parties, provided that AMD reasonably determines that substantial
sales revenues for AMD may be generated from such region. 
  
 9.3
Warranty, Field Support. AMD will reasonably assist FASL and Customers in connection with FASL’s compliance with and fulfillment of its warranty policies and, specifically, with respect to the following FASL processes: Return Material
Authorizations (RMAs); Customer Corrective Action Requests (CCARs); and Advanced Change Notifications (ACNs). **** written notification to AMD, and AMD will assist FASL in accordance with the revised processes, provided that **** would
require AMD to incur significant additional costs or compliance burdens, unless AMD consents thereto in writing, such consent not to be unreasonably conditioned, delayed or withheld. 
  
 9.4 Subdistributor Channel Design Registration. AMD will assist FASL and Customers regarding Subdistribution Channel
Design Registrations on terms and conditions, and in accordance with procedures, to be agreed by the Parties. 
  
 10. CHANGES IN SPECIFICATIONS AND DESIGNS 
  
 10.1 Product Transition. FASL will initially manufacture the Products set forth on Schedule 10.1 in accordance with the specifications used
for such Products immediately prior to the Effective Date, and will label and market such Products under the Product part numbers used for such Products by AMD immediately prior to the Effective Date, for a reasonable period of time as reasonably
determined by FASL, taking into account various factors, including the preservation of Customer relationships and Customer demands and requirements. 
  
 10.2 Product Change or Elimination (End-of-Life). With respect to any proposed change to the specifications or designs of any Product, or to a
proposed change to cease further production of a Product, FASL shall notify AMD of the proposed change in accordance with FASL’s then-current standard ACN procedures, a copy of which FASL shall provide to AMD from time to time, as and when
updated. FASL will then commercially release such change, or phase out production of a Product, in accordance with its then-current standard ACN procedures; provided, however, ****. 
  
 11. MARKETING; SALES 
  

 14 
  

 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as ****. A complete version of the exhibit has been filed separately with the securities and Exchange Commission 

 11.1 Global Marketing Policies and Campaign.  
  
 11.1.1 Marketing Policies. FASL will establish global policies
regarding public relations and marketing, including the form and content of Product marketing and promotional materials and advertisements, such policies to be amended by FASL from time to time in its reasonable discretion. FASL shall promptly
notify AMD in writing of any amendments to such policies. AMD shall comply with such policies, to the extent permitted by Applicable Law. 
  
 11.1.2 Marketing Campaign. FASL will, on an annual basis, develop a global marketing plan for Products, in consultation with AMD and Fujitsu (each,
a “Marketing Plan”). Each Party will be responsible for performing the obligations under each Marketing Plan which such Party has agreed to in writing, and shall bear all costs and expenses it has agreed in writing to bear in
connection therewith. FASL will update each Marketing Plan on an as-needed basis. ****. 
  
 11.2 Joint Marketing.  
  
 11.2.1 Restriction. If agreed in writing by the Parties, AMD may engage in joint marketing or promotional campaigns in which both Parties are referenced. The Parties agree and acknowledge that using FASL-produced marketing materials
and the Trademarks in connection with AMD’s normal sales activities (including by modifying FASL marketing materials for incorporation into AMD’s general product marketing materials in accordance with Section 11.6.2) shall not constitute a
joint marketing campaign. 
  
 11.2.2 Joint Campaign Activities
and Costs. Notwithstanding Section 11.2.1, AMD may request that FASL establish and implement a joint marketing campaign. Upon such request, FASL may agree to establish such a joint marketing campaign on terms to be agreed. ****. 
  
 11.2.3 FASL Support. Upon AMD’s request, FASL may, but ****,
participate in AMD-led marketing activities directed at a specific Customer or group of Customers within the AMD Territory or the Joint Territory, or at any **** AMD **** Customer. FASL’s decision as to whether it will participate in such
activities will ****. 
  
 11.3 Market Intelligence. AMD
will use commercially reasonable efforts to keep FASL informed of industry trends and competitive conditions that may affect the sale of Products in the AMD Territory, and will use commercially reasonable efforts to provide FASL with such
information for regions in the Joint Territory to the extent AMD becomes aware of such trends or conditions. 
  
 11.4 **** Efforts. AMD will **** from time to time, and will use commercially reasonable efforts to ****, in each case ****. AMD will use
commercially reasonable efforts to****. 
  

 15 
  

 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as ****. A complete version of the exhibit has been filed separately with the securities and Exchange Commission 

 11.5 ****.  
  
 11.5.1 Activities. AMD will engage in the following **** and ****, and, to the extent commercially reasonable, with
**** and ****, provided that such **** are consistent with the then-current ****: 
  
 (a) **** 
  
 (b)
**** 
  
 (c) **** 
  
 (d) ****, to the extent permitted by and in accordance with Applicable Law
and subject to **** and any duty of confidentiality that AMD owes to any third party; and 
  
 (e) Performing such other activities that AMD reasonably determines to be useful ****. 
  
 11.5.2 Marketing Support. FASL will, at FASL’s sole cost, provide AMD with all marketing application support reasonably requested by AMD in
connection with AMD’s ****, including by providing AMD with a **** for use in connection with ****. 
  
 11.6 Marketing Materials.  
  
 11.6.1 Customization Assistance. AMD will, upon FASL’s reasonable request, assist FASL with the customization of FASL’s Product marketing
and promotional materials for particular geographic regions within the AMD Territory and the Joint Territory and for specifically ****. Any assistance that AMD provides in accordance with this Section 11.6.1 shall be at ****, provided that
such costs are reasonably incurred. 
  
 11.6.2 Marketing
Materials. FASL will be solely responsible for producing general Product marketing and promotional materials. FASL will provide AMD with a reasonable amount of such materials, including for the purpose of enabling AMD to engage in **** pursuant
to Section 11.5. AMD shall have the right at its own cost to modify such materials in order to incorporate FASL marketing materials into AMD’s general product marketing materials in such a manner that conforms with AMD’s general marketing
practices. 
  
 11.7 Training. AMD will train all AMD field
sales personnel, sales support personnel, and field applications personnel engaged in the promotion and sale of Products, and will provide training to such personnel of its Channel Partners to the extent it reasonably determines that its Channel
Partners require such training. FASL will assist AMD with such training efforts, on terms and conditions to be agreed by the Parties. 
  

 16 
  

 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as ****. A complete version of the exhibit has been filed separately with the securities and Exchange Commission 

 11.8 Other Assistance. AMD shall provide FASL with such additional sales and/or marketing support
activities as FASL may reasonably request from time to time, on terms and conditions to be agreed in writing by the Parties. 
  
 12. PRICE; PAYMENTS; TAXES 
  

12.1 Distributor Pricing. AMD is free to establish prices for its re-sale of Products. 
  
 12.2 Price List. **** The Parties will use Best Efforts to ****, but
acknowledge that on the Effective Date means to establish such a procedure have not been implemented. Price changes shall apply to all Purchase Orders **** and FASL may in its discretion **** received prior to the effective date of the change. FASL
will establish policies and procedures whereby FASL will honor long-term pricing commitments to AMD as agreed to by FASL. 
  
 12.3 Purchase Price of FASL Content Only Products. The Purchase Price for each FCO Product shall be equal to **** at the time the order was booked.
The Purchase Price for each FCO Product ****: 
  
 12.3.1 Price
Increase. In the event AMD sells an FCO Product to a Customer or Channel Partner ****. 
  
 12.3.2 Price Decrease. In the event AMD sells an FCO Product to a Customer or Channel Partner ****. 
  
 12.4 Purchase Price for Combined Products.  
  
 12.4.1 Purchase Price. The Purchase Price for each Combined Product shall be as follows: 
  
 (a) **** 
  
 (b) **** 
  
 (c) **** 
  
 (d) **** 
  
 (e) **** 
  
 (f) **** 
  
 12.4.2 Price Increase. In the event AMD sells a Combined Product to a Customer or Channel Partner in an amount that is **** at the time the order
was booked for such Product, the Purchase Price shall **** to the ****. 
  

 17 
  

 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as ****. A complete version of the exhibit has been filed separately with the securities and Exchange Commission 

 12.4.3 Price Decrease. In the event AMD sells a Combined Product to a Customer or Channel Partner
in an amount that is **** at the time the order was booked for such Product, ****. 
  
 12.4.4 Determination of FASL Content. The percentage of FASL Content of any Combined Product shall be determined by FASL using the following formula: **** 
  
 **** 
  
 12.4.5 Content Review; Breakdown. FASL shall, on a Quarterly basis, review the percentage of FASL Content for each
Combined Product, and shall make adjustments to the ****, as required based on such review. For each Combined Product, FASL shall provide AMD with a **** of the non-FASL Content that was used in determining the percentage of FASL Content for such
Product. 
  
 12.5 Payments Terms. FASL shall issue and
deliver an invoice to AMD for any amount payable to FASL pursuant to this Agreement. Unless otherwise agreed by the Parties, payments for Products delivered in accordance with Section 2.3.3, and any other payments required hereunder, including
pursuant Section 11.2.2, shall be made within **** from the date on **** relating to such ****. In no event shall FASL deliver an invoice before shipping the Products (or, in the event of joint marketing costs payable in accordance with Section
11.2.2, incurring the costs) to which such invoice relates. If the end of the payment period falls on a non-business day of AMD, payment may be made on the following business day. All amounts payable by AMD to FASL shall be paid by wire transfer of
U.S. Dollars in immediately available funds to such financial institution and account number as FASL may designate in writing to AMD. ****. 
  
 12.6 Currency. All RSPs shall be quoted in ****. 
  
 12.7 Late Payments. If AMD fails to make any payment on or before the required payment date, AMD shall be liable for interest on such payment at
the rate of **** per annum or the maximum amount allowed by Applicable Law, whichever is less. 
  
 12.8 Taxes. All amounts payable for Product sold by FASL to AMD hereunder are exclusive of any taxes. AMD shall reimburse FASL only for the following tax payments with respect to the sale of Product under this
Agreement unless an exemption applies: state and local use taxes arising in the United States of America, value added taxes or other similar taxes on turnover (“VAT”) arising in relevant jurisdictions imposing VAT and consumption
taxes arising in Japan. FASL shall cause all such amounts reimbursed by AMD to be paid to the appropriate Governmental Authorities as required by Applicable Law. If FASL is required by law to charge use, consumption, VAT or similar taxes to AMD,
FASL will ensure its invoices are in proper form to enable AMD to claim VAT or other applicable deductions, if AMD is permitted by law to do so. In the event that AMD is required by Applicable Law to make any deduction or to withhold any amount from
any sum payable by AMD to FASL hereunder, (a) AMD will remit such amounts to the appropriate Governmental Authorities and promptly furnish FASL with 
  

 18 
  

 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as ****. A complete version of the exhibit has been filed separately with the securities and Exchange Commission 

 original tax receipts evidencing the payment of such amounts, and (b) the sum payable by AMD upon which the deduction or
withholding is based will be decreased accordingly. 
  
 13. ****
BUSINESS REVIEW 
  
 13.1
Meetings. AMD and FASL will meet ****, at a time and place to be agreed by the Parties. The Parties may attend these meetings in person, by telephone or via videoconference. Each Party will bear its own costs and expenses incurred in
connection with attending such meetings. AMD and FASL may hold such meetings jointly **** and/or any other distributor or sales representative appointed by FASL in accordance with Section 2.2 or 14, as FASL reasonably determines is appropriate and
subject to Sections 13.2 and 13.3. 
  
 13.2 Meeting Topics.
At these **** meetings, the Parties will, among other things: (a) ****, if applicable, **** undertaken in accordance with ****; (b) discuss ****; (c) discuss ****; (d) evaluate the ****; (e) evaluate the ****; and (f) discuss other issues and
concerns raised by the Parties. ****. Information obtained by FASL from AMD with regard to AMD’s independent sales activities, Product pricing or allocation shall be subject to the obligations set forth in Section 16, and shall not be disclosed
to Fujitsu or to any other Entity or person, except as otherwise expressly permitted hereunder, including without limitation as permitted under Section 9.1. 
  
 13.3 **** 
  
 14. DISTRIBUTOR CORRECTIVE ACTION 
  
 14.1 **** 
  
 14.1.1 **** 
  
 14.1.2 **** 
  
 14.1.3 **** 
  
 14.1.4 **** 
  
 **** 
  
 14.2 **** 
  
 14.2.1 **** 
  
 14.2.2 **** 
  
 14.2.3 **** 
  
 14.2.4 **** 
  

 19 
  

 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as ****. A complete version of the exhibit has been filed separately with the securities and Exchange Commission 

 14.2.5 **** 
  
 14.3 **** 
  
 14.3.1 **** 
  
 (a) **** 
  
 (b) **** 
  
 (c) **** 
  
 14.3.2 **** 
  
 14.3.3 **** 
  
 14.3.4 **** 
  
 15. WARRANTIES 
  
 15.1 FASL Product Warranty. FASL represents and warrants to AMD that the Products shall operate in accordance with the Documentation and other written specifications therefor, and shall be free from defects in functionality,
materials and workmanship, for a period of **** from the date that such Products **** in accordance with Section 3 (the “Warranty Period”). 
  
 15.2 Remedies. In the event that AMD notifies FASL during the applicable Warranty Period that any Product does not conform to the warranty
provisions set forth in Section 15.1, FASL shall, at FASL’s option, ****. 
  
 15.3 No Warranty Pass Through. AMD shall have the right to independently make Product warranties to Customers and Channel Partners consistent with the Product warranty made by FASL under this Agreement. ****.

  
 15.4 Disclaimer. EXCEPT AS OTHERWISE EXPRESSLY SET
FORTH IN THIS AGREEMENT, NEITHER PARTY MAKES (AND EACH PARTY HEREBY EXPRESSLY DISCLAIMS) ANY REPRESENTATIONS OR WARRANTIES, WHETHER EXPRESS, IMPLIED OR STATUTORY, INCLUDING ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE
OR NON-INFRINGEMENT, AND ANY WARRANTIES THAT MAY ARISE FROM COURSE OF PERFORMANCE, COURSE OF DEALING OR USAGE OF TRADE. 
  
 16. CONFIDENTIAL INFORMATION 
  
 16.1 Obligations. The Parties acknowledge and agree that all proprietary or nonpublic information disclosed by one Party (the “Disclosing
Party”) to the other Party (the “Receiving Party”) in connection with this Agreement, directly or indirectly, which information is 
  

 20 
  

 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as ****. A complete version of the exhibit has been filed separately with the securities and Exchange Commission 

 (a) marked as “proprietary” or “confidential” or, if disclosed orally, is designated as confidential
or proprietary at the time of disclosure and reduced in writing or other tangible (including electronic) form that includes a prominent confidentiality notice and delivered to the Receiving Party within thirty (30) days of disclosure, or (b)
provided under circumstances reasonably indicating that it constitutes confidential and proprietary information, constitutes the confidential and proprietary information of the Disclosing Party (“Confidential Information”). The
Receiving Party may disclose Confidential Information only to those employees who have a need to know such Confidential Information and who are bound to retain the confidentiality thereof under provisions (including provisions relating to nonuse and
nondisclosure) no less restrictive than those required by the Receiving Party for its own confidential information. The Receiving Party shall, and shall cause its employees to, retain in confidence and not disclose to any third party (including any
of its sub-contractors) any Confidential Information without the Disclosing Party’s express prior written consent, and the Receiving Party shall not use such Confidential Information except to exercise the rights and perform its obligations
under this Agreement. Without limiting the foregoing, the Receiving Party shall use at least the same procedures and degree of care which it uses to protect its own confidential information of like importance, and in no event less than reasonable
care. The Receiving Party shall be fully responsible for compliance by its employees with the foregoing, and any act or omission of an employee of the Receiving Party shall constitute an act or omission of the Receiving Party. The confidentiality
obligations set forth in this Section 16.1 shall apply and continue, with regard to all Confidential Information disclosed hereunder, during the Term (as hereinafter defined) and for a period of five (5) years from the date of termination of this
Agreement. 
  
 16.2 Exceptions. Notwithstanding the
foregoing, Confidential Information will not include information that: (a) was already known by the Receiving Party, other than under an obligation of confidentiality to the Disclosing Party or any third party, at the time of disclosure hereunder,
as evidenced by the Receiving Party’s tangible (including written or electronic) records in existence at such time; (b) was generally available to the public or otherwise part of the public domain at the time of its disclosure to the Receiving
Party hereunder; (c) became generally available to the public or otherwise part of the public domain after its disclosure other than through any act or omission of the Receiving Party in breach of this Agreement; (d) was subsequently lawfully
disclosed to the Receiving Party by an Entity or person other than the Disclosing Party not subject to any duty of confidentiality with respect thereto; or (e) was developed by the Receiving Party without reference to any Confidential Information
disclosed by the Disclosing Party, as evidenced by the Receiving Party’s tangible (including written or electronic) records in existence at such time. 
  
 16.3 Confidentiality of Agreement; Publicity. Each Party agrees that the terms and conditions of this Agreement shall be treated as Confidential
Information and that no reference shall be made thereto without the prior written consent of the other Party (which consent shall not be unreasonably withheld) except (a) as required by Applicable Law, provided that in the case of any filing
with a Governmental Authority that would result in public disclosure of the terms hereof, the Parties shall mutually cooperate to limit the scope of public disclosure to the greatest extent possible, (b) to its accountants, banks, financing sources,
lawyers and other professional advisors, provided that such parties undertake in writing (or are otherwise bound by 
  

 21 
  

 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as ****. A complete version of the exhibit has been filed separately with the securities and Exchange Commission 

 rules of professional conduct) to keep such information strictly confidential, (c) in connection with the enforcement of
this Agreement, or (d) pursuant to agreed joint press releases prepared in good faith. The Parties will consult with each other, in advance, with regard to the terms of all proposed press releases, public announcements and other public statements
with respect to the transactions contemplated hereby. 
  
 17.
CONSEQUENTIAL DAMAGES WAIVER 
  
 TO THE EXTENT PERMITTED BY APPLICABLE LAW, IN NO EVENT SHALL EITHER PARTY BE LIABLE TO THE OTHER PARTY, OR ANY THIRD PARTY CLAIMING THROUGH OR UNDER SUCH PARTY, UNDER ANY LEGAL THEORY, FOR ANY COSTS (INCLUDING WITHOUT
LIMITATION LABOR COSTS) FOR IN-THE-FIELD INSTALLATION OR REPAIR WORK, OR FOR OTHER SIMILAR REWORK COSTS, OR FOR ANY LOSS OF PROFITS, REVENUES OR GOODWILL, LOSS OF DATA, OR FOR ANY INDIRECT, SPECIAL, INCIDENTAL OR CONSEQUENTIAL DAMAGES, EVEN IF SUCH
PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. THE FOREGOING PROVISIONS OF THIS SECTION 17 SHALL NOT BE DEEMED TO LIMIT FASL’S INDEMNITY OBLIGATIONS UNDER SECTION 19. 
  
 18. LIMITATION OF LIABILITY 
  
 EXCEPT WITH RESPECT TO FASL’S INDEMNITY OBLIGATIONS UNDER SECTION 19,
NOTWITHSTANDING ANY OTHER PROVISION OF THIS AGREEMENT, AND TO THE EXTENT PERMITTED BY APPLICABLE LAW, EACH PARTY’S AGGREGATE LIABILITY TO THE OTHER PARTY OR ANY THIRD PARTY FOR CLAIMS RELATING TO THIS AGREEMENT, WHETHER FOR BREACH, NEGLIGENCE,
INFRINGEMENT, IN TORT OR OTHERWISE, SHALL BE LIMITED TO AN AMOUNT EQUAL TO THE ****. 
  
 19. FASL INDEMNITY 
  
 19.1
Indemnity. FASL shall at its own expense defend AMD from and against any (a) third party action to the extent that it relates to or results from any defects of Products delivered by or for FASL that directly result in the death or bodily
injury to any person or that result in damage to real or personal property, or (b) any third party claim, action or proceeding to the extent that it relates to or results from the Products allegedly infringing, violating or misappropriating any
Intellectual Property Right of any third party (collectively, clauses (a) and (b) constitute “Claims”). For purposes of this Section 19, the term Intellectual Property Rights shall be limited to patents, copyrights, mask work rights, trade
secrets and Trademarks; provided, however, that for purposes of this Section 19, the term Trademarks shall be limited to those Trademarks where FASL (or its subcontractors or agents), and not AMD or Fujitsu, has performed the research and
registration work to validate the availability of the Trademark in the 
  

 22 
  

 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as ****. A complete version of the exhibit has been filed separately with the securities and Exchange Commission 

 applicable jurisdictions. FASL agrees to indemnify AMD and hold it harmless from and against any damages, costs and
expenses (including without limitation any reasonable attorneys’ fees and costs) finally awarded against AMD by a court of competent jurisdiction that may result from any such Claim; provided that (i) AMD notifies FASL promptly in writing of
the Claim; (ii) FASL has sole control of the defense and all related settlement negotiations; and (iii) AMD provides FASL, at FASL’s expense, with all reasonable assistance, information, and authority to perform these duties. Any delay by AMD
in notifying FASL of a Claim shall not relieve FASL of its obligations under this Section 19, except to the extent (and only to the extent) that FASL’s ability to defend such Claim is materially prejudiced by such delay. 
  
 19.2 Exclusions. FASL shall have no liability for any Claim of
infringement or liability based on or arising from (i) modification of the Products by AMD or any third party (unless such modification was specifically authorized or required by FASL and such authorization was delivered by an authorized FASL
employee in the form of a detailed written requirements document listing in detail the specifications for the modification), to the extent the infringement or liability would have been avoided by use of the unmodified Products; or (ii) the
combination or use of the Products furnished hereunder with materials or technology not furnished by FASL, to the extent such infringement or liability would have been avoided by use of the Products alone. 
  
 19.3 Alternatives. In the event the Products are held to, or FASL
believes are likely to be held to, infringe, violate or misappropriate any Intellectual Property Right of any third party, FASL shall have the right at its sole option and expense to (i) substitute or modify the Products so that they are
non-infringing, while retaining substantially equivalent features and functionality as set forth in the specifications and documentation; or (ii) obtain for AMD a license to continue offering the Products; or (iii) if (i) and (ii) are not reasonably
practicable as determined by FASL, terminate further sales of the infringing Product. 
  
 19.4 Limit on Liability. In no event shall FASL’s liability for (i) Claims relating to infringement, violation or misappropriation of third party Intellectual Property Rights, or (ii) Claims for loss of
data exceed the amounts paid to AMD or its Affiliates by their respective Customers or Channel Partners for the affected Products. 
  
 19.5 Sole Obligation. The foregoing FASL indemnities state the sole obligation and exclusive liability of FASL to AMD, and AMD’s sole recourse
and remedy against FASL for any Claim of infringement or misappropriation of an Intellectual Property Right by the Products or for any Claim of product liability related to the Products. 
  
 20. TERM AND TERMINATION 
  
 20.1 Term. This Agreement will be effective as of the Effective Date, and will continue in full force and
effect indefinitely, unless terminated as set forth in this Section 20 (“Term”). 
  
 20.2 Termination upon Mutual Agreement. The Parties may terminate this Agreement upon mutual written consent at any time. 
  

 23 
  

 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as ****. A complete version of the exhibit has been filed separately with the securities and Exchange Commission 

 20.3 Termination for Breach. In the event that either Party materially defaults in the performance
of a material obligation under this Agreement, then the non-defaulting Party may provide written notice to the defaulting Party indicating: (a) the nature and basis of such default with reference to the applicable provisions of this Agreement; and
(b) the non-defaulting Party’s intention to terminate this Agreement. Upon receipt of such notice, the defaulting Party shall use Best Efforts to cure the alleged breach in a timely manner, and the Parties shall meet to discuss the matter. If
the breach has not been cured to the reasonable satisfaction of the non-defaulting Party within a reasonable period of time of not less than ****, and if the Parties are not otherwise able to resolve the matter, then the non-defaulting Party may
terminate this Agreement upon written notice. 
  
 20.4 ****

  
 20.5 Cross-Termination. Unless otherwise
expressly agreed in writing by the Parties, this Agreement shall automatically terminate upon the termination of the LLC Operating Agreement. 
  
 20.6 Effect of Termination. 
  
 20.6.1 Return of Confidential Information. 
  
 (a) AMD shall promptly return to FASL (or destroy, at FASL’s election) all Documentation and FASL Confidential Information then in the possession or
under AMD’s control, and FASL shall promptly return to AMD (or destroy, at AMD’s election) all AMD Confidential Information then in the possession or under FASL’s control, ****. 
  
 (b) Notwithstanding subsection (a) above, the Receiving Party shall not be
liable to the Disclosing Party for the inadvertent use of the Disclosing Party’s Residual Information for the Receiving Party’s own business purposes by the Receiving Party’s personnel who no longer have access to any tangible
(including machine-readable) embodiments of any Confidential Information of the Disclosing Party; provided, however, that the foregoing shall not release or excuse the Receiving Party from any liability to the Disclosing Party for any
disclosure of the Disclosing Party’s Confidential Information by the Receiving Party to any other persons or Entities, including the Receiving Party’s former personnel, or any use of such Confidential Information by such other persons or
Entities. This subsection (b) shall not be deemed to (A) grant to the Receiving Party a license under any Intellectual Property Rights (excluding trade secrets) of the Disclosing Party or (B) authorize any use of the tangible (including
machine-readable) embodiments of any Confidential Information of the Disclosing Party. For purposes hereof, “Residual Information” means with respect to Confidential Information, information in non-tangible form which may be
incidentally retained in the unaided memory of the Receiving Party’s personnel having had access to the Confidential Information of the Disclosing Party, and which such personnel cannot identify as Confidential Information of the Disclosing
Party. Such personnel’s memory is “unaided” if the personnel have not intentionally memorized any Confidential Information of the Disclosing Party. 
  

 24 
  

 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as ****. A complete version of the exhibit has been filed separately with the securities and Exchange Commission 

 20.6.2 Limitation of Liability. Neither FASL nor AMD shall be liable to the other, because of such
termination, for compensation, reimbursement or damages: (i) for the loss of prospective profits, anticipated sales or goodwill; (ii) on account of any expenditures, investments or commitments made by either; or (iii) for any other reason whatsoever
based upon the result of such termination. 
  
 20.6.3
Continuing Liability. The termination of this Agreement for any reason shall not release either Party from any liability, obligation or agreement which has already accrued at the time of termination. Termination of this Agreement for any
reason shall not constitute a waiver or release of, or otherwise be deemed to prejudice or adversely affect, any rights, remedies or claims, whether for damages or otherwise, which a Party may have hereunder, at law or otherwise, or which may arise
out of or in connection with such termination. 
  
 20.6.4
Outstanding Purchase Order Fulfillment. FASL shall complete all Purchase Orders that have been previously accepted by FASL and not specifically cancelled upon termination by AMD, and shall accept and fulfill any Purchase Orders issued by AMD
for a period of **** after termination of this Agreement, provided that the reason for termination was not a failure by AMD to pay amounts previously due to FASL under this Agreement; provided, further, that all inventories held by or
on behalf of AMD and its Channel Partners shall be depleted by the end of such****. During such period, AMD shall have no guaranteed allocation and FASL may freely appoint additional distributors in the AMD Territory and the Joint Territory, and
with respect to ****, AMD Affiliates and AMD PRC Customers, unless otherwise restricted pursuant to the terms of the Fujitsu Distribution Agreement. 
  
 20.6.5 Payment Obligation. AMD shall pay for all Products previously delivered by FASL and all Products subsequently delivered by FASL pursuant to
the Purchase Orders referred to in Section 20.6.4. 
  
 20.6.6
Trademark and Documentation Licenses. All licenses relating to Trademarks and Documentation shall terminate, provided, however, that AMD shall have the right to continue to use Trademarks and Documentation, in a manner consistent with
Section 6, in connection with the sale of Products in accordance with Section 20.6.4. 
  
 20.6.7 ****. If this Agreement terminates at any time prior to ****pursuant to Section 2.1, then FASL may elect to transition such AMD **** effective upon the termination date either ****, regardless of the time
periods or other requirements that may be set forth in Section 2.1 above. Unless termination resulted from a material breach by FASL, then AMD agrees to use Best Efforts to ****. 
  
 20.7 Survival. The provisions of Sections 3 (for purposes of fulfilling the terms of Section 20.6.4), 12, 15, 16 (in
accordance with its terms), 17, 18, 19, 20.6, 20.7 and Section 21 shall survive any termination of this Agreement. 
  
 21. MISCELLANEOUS TERMS 
  

 25 
  

 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as ****. A complete version of the exhibit has been filed separately with the securities and Exchange Commission 

 21.1 Relationship of the Parties. In the exercise of their respective rights, and the performance
of their respective obligations hereunder, the Parties are, and will remain independent contractors. Nothing in this Agreement will be construed to constitute the Parties as partners, or principal and agent for any purpose whatsoever. Neither Party
will bind, or attempt to bind, the other Party hereto to any contract or other obligation, and neither Party will represent to any third party that it is authorized to act on behalf of the other Party to this Agreement. 
  
 21.2 Governing Law. This Agreement will be governed by and construed
in accordance with the laws of the State of California, United States of America, as applied to agreements among California residents entered into and wholly to be performed within the State of California (without reference to any choice or
conflicts of laws rules or principles that would require the application of the laws of any other jurisdiction and without regard to the United Nations Convention on Contracts for the International Sale of Goods). 
  
 21.3 Dispute Resolution. Any dispute arising under or relating to this
Agreement shall be resolved in accordance with the dispute resolution procedures set forth in the LLC Operating Agreement, which procedures are incorporated herein and deemed to apply mutatis mutandis to the Parties. 
  
 21.4 Language. This Agreement is in the English language only, which
language shall be controlling in all respects, and all versions hereof in any other language shall be for accommodation only and shall not be binding upon the Parties. All communications and notices to be made or given pursuant to this Agreement
shall be in the English language. 
  
 21.5 Successors and
Assigns. Except as expressly provided herein, the rights and obligations hereunder may not be assigned or delegated by either Party without the prior written consent of the other Party; provided, however, that AMD shall have the right to
assign this Agreement in connection with the sale of substantially all of its business to which the Products relate. Any purported assignment, sale, transfer, delegation or other disposition of such rights or obligations by either Party, except as
permitted herein, shall be null and void. Subject to the foregoing, this Agreement shall be binding upon and shall inure to the benefit of the Parties and their respective successors and permitted assigns. 
  
 21.6 Entire Agreement; Amendment. This Agreement (including the
Schedules and Exhibits hereto) and the other Transaction Documents constitute the full and entire understanding and agreement between the Parties with regard to the subject matter hereof, and supercede any prior communications, representations,
understandings and agreements, either oral or written, between the Parties with respect to such subject matter. This Agreement may not be altered except by a written instrument signed by authorized legal representatives of both Parties and Fujitsu.
Any waiver of the provisions of this Agreement or of a Party’s rights or remedies under this Agreement must be in writing to be effective. Failure, neglect or delay by a Party to enforce the provisions of this Agreement or its rights or
remedies at any time will not be construed and will not be deemed to be a waiver of such Party’s rights under this Agreement and will not in any way affect the validity of the whole or any part of this Agreement or prejudice such Party’s
right to take subsequent action. No single or partial exercise of any right, power or privilege granted under this Agreement shall preclude any other or further exercise thereof or the 
  

 26 
  

 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as ****. A complete version of the exhibit has been filed separately with the securities and Exchange Commission 

 exercise of any other right, power or privilege. The rights and remedies provided in this Agreement are cumulative and
are not exclusive of any rights or remedies provided by law. 
  
 21.7 Notices and Other Communications. All notices required or permitted under this Agreement shall reference this Agreement and will be deemed given: (a) when delivered personally; (b) when sent by confirmed facsimile; (c) five (5)
business days after having been sent by registered or certified mail, return receipt requested, postage prepaid; or (d) three (3) business days after deposit with an internationally recognized commercial overnight carrier specifying next-day
delivery, with written verification of receipt. All such notices, requests, demands and other communications shall be addressed as follows: 
  
 If to FASL: 
  
 FASL LLC 
 One
AMD Place M/S 150 
 P.O. Box 3453 
 Sunnyvale, CA 94086 
 Attention: General Counsel 
 Telephone: (408) 749-2400 
 Facsimile: (408) 774-7399 
  
 If to AMD: 
 Advanced MicroDevices, Inc. 
 One AMD Place M/S 150 
 P.O. Box 3453 
 Sunnyvale, CA 94086 
 Attention: General Counsel 
 Telephone: (408) 749-2400 
 Facsimile: (408) 774-7399 
  
 or to such other
address or facsimile number as a Party may have specified to the other Party in writing delivered in accordance with this Section 21.7. 
  
 21.8 Expenses. Except as otherwise expressly set forth in this Agreement, each Party will bear its own costs and expenses, including fees and
expenses of legal counsel and other representatives used or hired in connection with the transactions described in this Agreement. 
  
 21.9 Force Majeure. 
  
 21.9.1 Excuse. Neither Party will be liable to the other for failure or delay in performing its obligations hereunder if such failure or delay is
due to circumstances beyond its reasonable control, including acts of any governmental body, war, terrorism, insurrection, 
  

 27 
  

 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as ****. A complete version of the exhibit has been filed separately with the securities and Exchange Commission 

 sabotage, embargo, fire, flood, earthquake, strike or other labor disturbance, interruption of or delay in
transportation, or unavailability of or interruption or delay in telecommunications or third party services (“Force Majeure”); provided, however, that (a) a lack of credit, funds or financing, or (b) strikes or other labor
disturbances that are limited to FASL’s employees shall not constitute Force Majeure. This Section 21.9.1 shall not be interpreted as relieving a Party of an obligation to pay, but may serve to excuse delay in making a payment when due.

  
 21.9.2 Mitigation. A Party seeking to be excused from
performance as the result of Force Majeure will be excused to the extent such performance is delayed or prevented by Force Majeure, provided that such Party shall use the utmost reasonably practicable efforts to complete such performance.
Each Party agrees to resume performance with the utmost dispatch whenever the causes of such excuse are cured or remedied. 
  
 21.9.3 Notice. Should any Party be prevented from or delayed in or become aware that it is likely to be prevented from or delayed in carrying out
its obligations under this Agreement due to Force Majeure, such Party shall promptly give to the other Party a written notice setting forth the details of such Force Majeure. 
  
 21.10 Severability. If any provision in this Agreement will be found or be held to be invalid or unenforceable, then
the meaning of said provision will be construed, to the extent feasible, so as to render the provision enforceable, and if no feasible interpretation would save such provision, it will be severed from the remainder of this Agreement which will
remain in full force and effect unless the severed provision is essential and material to the rights or benefits received by any Party. In such event, the Parties will use their respective Best Efforts to negotiate, in good faith, a substitute,
valid and enforceable provision or agreement which most nearly effects the Parties’ intent in entering into this Agreement. 
  
 21.11 No Third Party Beneficiaries. The terms and provisions of this Agreement are intended solely for the benefit of each Party and their
respective successors and permitted assigns, and the Parties do not intend to confer third party beneficiary rights upon any other Entity or person. 
  
 21.12 Construction. This Agreement shall be deemed to have been drafted by both Parties and, in the event of a dispute, no Party hereto shall be
entitled to claim that any provision should be construed against any other Party by reason of the fact that it was drafted by one particular Party. 
  
 21.13 Execution. This Agreement may be executed in counterparts, each of which so executed will be deemed to be an original and such counterparts
together will constitute one and the same agreement. Execution and delivery of this Agreement by exchange of facsimile copies bearing the facsimile signature of a Party shall constitute a valid and binding execution and delivery of this Agreement by
such Party. 
  

 28 
  

 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as ****. A complete version of the exhibit has been filed separately with the securities and Exchange Commission 

 IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed and delivered by their
respective duly authorized representatives as of the date first above written. 
  

	 FASL LLC:

		
	 By:
	 	 /s/    THOMAS M.
MCCOY      

	 Name:
	 	Thomas M. McCoy
	 Title:
	 	Manager

  

	 ADVANCED MICRO DEVICES, INC.:

		
	 By:
	 	 /s/    THOMAS M.
MCCOY      

	 Name:
	 	Thomas M. McCoy
	 Title:
	 	Senior Vice President, General Counsel

  

 29 
  

 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as ****. A complete version of the exhibit has been filed separately with the securities and Exchange Commission

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00054-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00054-of-00352.parquet"}]]